Peter HOLZER

Mag. rer. nat. Dr. phil.
Univ.-Prof. für Experimentelle Neurogastroenterologie

Leiter der ► Forschungseinheit für Translationale Neurogastroenterologie

Otto-Loewi-Forschungszentrum
der Medizinischen Universität Graz
Universitätsplatz 4, A-8010 Graz, Austria

Tel.: +43 (316) 380-4500
Fax: +43 (316) 380-9645
e-mail:  peter.holzer @ medunigraz.at

 

Forschungstätigkeiten Wissenschaftlicher Lebenslauf Publikationsliste
Publikationsliste / List of Publications
Key publications marked by and are also listed in a separate file.
Some of these publications are also available as PDF-files (click on the PDF icon).
 
Journal Articles Book Chapters Books, Whole Conference Proceedings Other Publications Invited Lectures

279. Holzer P (2011) Non-analgesic effects of opioids. Management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal? Curr Pharm Designs (in press).

278. Ackbar R, Malvasio V, Holzer P, Saxena AK (2011) In vitro effect of bethanechol and suberyldicholine on regions of guinea pig esophagus. J Surg Res (in press).

277. Painsipp E, Herzog H, Sperk G, Holzer P (2011) Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y. Br J Pharmacol 163: 1302-1314.

276. Painsipp E, Köfer MJ, Sinner F, Holzer P (2011) Prolonged depression-like behavior caused by immune challenge: influence of mouse strain and social environment. PLoS One 6:e20719.

275. Post AM, Weyers P, Holzer P, Painsipp E, Pauli P, Wultsch T, Reif A, Lesch KP (2011) Gene-environment interaction influences anxiety-like behavior in ethologically based mouse models. Behav Brain Res 218:99-105.

274. Holzer P (2011) Acid sensing by visceral afferent neurons. Acta Physiol 201:63-75.

273. Holzer P (2011) Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol Ther 131:142-170.

272. Holzer P (2011) Darmdysfunktion als "Keim" affektiver Störungen. Jatros Neurologie und Psychiatrie 1/2011:22-23.

271. Holzer P (2011) Mehr als ein After-Dinner-Mint: Pfefferminze für Reizdarm und Reizmagen. Universum Innere Medizin (Sonderbeilage Gastroenterologie) 03/11:8-9.

270. Holzer P (2011) TRP channels in the digestive system. Curr Pharm Biotechnol 12:24-34.

269. Holzer P (2010) Opioid antagonists for prevention and treatment of opioid induced gastrointestinal effects. Curr Opin Anesthesiol 23:616-622.

268. Schmidt R, Bach M, Dal-Bianco P, Holzer P, Pluta-Fuerst A, Assem-Hilger E, Lechner A, Cavalieri M, Haider B, Schmidt H, Pinter G, Pipam W, Stögmann E, Lampl C, Likar R (2010) Dementia and pain. Neuropsychiatrie 24:1-13.

267. Painsipp E, Herzog H, Holzer P (2010) Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signalling prevents long-term depression-like behavior caused by immune challenge. J Psychopharmacol 24:1551-1560.

266. Painsipp E, Sperk G, Herzog H, Holzer P (2010) Delayed stress-induced differences in locomotor and depression-related behaviour in female neuropeptide-Y Y1 receptor knockout mice. J Psychopharmacol 24:1541-1549.

265. Mitrovic M, Shahbazian A, Bock E, Pabst MA, Holzer P (2010) Chemo-nociceptive signalling from the colon is enhanced by mild colitis and blocked by inhibition of transient receptor potential ankyrin 1 channels. Br J Pharmacol 160:1430-1442.

264. Holzer P (2010) Kurzbewertung Methylnaltrexon. Arzneimittel-,Therapie-Kritik 2010/Folge 3:227-232.

263. Holzer P (2010) Kurzbewertung Methylnaltrexon. Internistische Praxis 2010/Folge 3:625-630.

262. Holzer P (2010) Chronische und opioidinduzierte Obstipation: Gewappnet mit neuen medikamentösen Ansätzen. Universum Innere Medizin (Sonderbeilage Gastroenterologie) 01/10:6-7.

261. Beubler E, Holzer P (2009) Opioidinduzierte Obstipation. Universum Innere Medizin 04/09:8-9.

260. Osterbrink J, Fiegl M, Holzer P, Kober A (2009) Therapeutisches Management der Opioid-induzierten Obstipation in der Palliativmedizin unter besonderer Berücksichtigung pflegerelevanter Aspekte. Int Zeitschr ärztl Fortbldg Juli 2009:1-6.

259. Edelsbrunner ME, Painsipp E, Herzog H, Holzer P (2009) Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake. Neuropeptides 43:491-497.

258. Painsipp E, Shahbazian A, Holzer P (2009) Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats. Br J Pharmacol 158:1210-1226.

257. Edelsbrunner ME, Nakano M, Holzer P (2009) Afferent signalling from the acid-challenged rat stomach is inhibited and gastric acid elimination is enhanced by lafutidine. BMC Gastroenterol 9:40.

256. Edelsbrunner ME, Herzog H, Holzer P (2009) Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner. Behav Brain Res 203:97-107.

255. Holzer P, Holzer-Petsche U (2009) Pharmacology of inflammatory pain: local alteration in receptors and mediators. Dig Dis 27 Suppl 1:24-30.

254. Herbert MK, Holzer P (2009) Therapie der gestörten Magen-Darm-Motilität bei Intensivpatienten. Anästhesiol Intensivmed 50:602-616.

253. Holzer P, Ahmedzai SH, Niederle N, Leyendecker P, Hopp M, Bosse B, Spohr I, Reimer K (2009) Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management. J Opioid Manag 5:145-151.

252. Holzer P (2009) Opioid receptors in the gastrointestinal tract. Regul Pept 155:11-17.

251. Holzer P, Watzke H (2009) Methylnaltrexon. ArzneimittelPROFIL Methylnaltrexon Februar 2009:1-11.

250. Reimer K, Hopp M, Zenz M, Maier C, Holzer P, Mikus G, Bosse B, Smith K, Buschmann-Kramm C, Leyendecker P (2008) Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach. Pharmacology 83:10-17.

249. Holzer P (2008) The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor. Br J Pharmacol 155:1145-1162.

248. Painsipp E, Herzog H, Holzer P (2008) Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice. Neuropharmacology 55:117-126.

247. Holzer P (2008) TRPV1: a new target for treatment of visceral pain in IBS? Gut 57: 882-884.

246. Holzer P (2008) New approaches to the treatment of opioid-induced constipation. Eur Rev Med Pharmacol Sci 12(Suppl 1): 119-127.

245. Barthó L, Benko R, Holzer-Petsche U, Holzer P, Undi S, Wolf M (2008) Role of extrinsic afferent neurons in gastrointestinal motility. Eur Rev Med Pharmacol Sci 12(Suppl 1): 21-31.

244. Holzer P (2008) Methylnaltrexone for the management of unwanted peripheral opioid effects. Therapy 5: 531-543.

243. Painsipp E, Wultsch T, Edelsbrunner ME, Tasan RO, Herzog H, Holzer P (2008) Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice. Genes Brain Behav 7: 532-542.

242. Herbert MK, Holzer P (2008) Standardized concept for the treatment of gastrointestinal dysmotility in critically ill patients - Current status and future options. Clin Nutrition 27: 25-41.

241. Fruhwald S, Holzer P, Metzler H (2008) Gastrointestinal motility in acute illness. Wien Klin WochenSchr 120: 6-17.

240. Wultsch T, Painsipp E, Shahbazian A, Mitrovic M, Edelsbrunner M, Waldmann R, Lazdunski M, Holzer P (2008) Deletion of the acid-sensing ion channel ASIC3 prevents gastritis-induced acid hyperresponsiveness of the stomach-brainstem axis. Pain 134: 245-253.

239. Holzer P (2007) Grundlagen der Schmerzpathologie. WMW Skriptum 4 (Heft 12.07): 8-10.

238. Holzer P (2007) Role of visceral afferent neurons in mucosal inflammation and defense. Curr Opin Pharmacol 7: 563-569.

237. Painsipp E, Wultsch T, Shahbazian A, Edelsbrunner M, Kreissl MC, Schirbel A, Bock E, Pabst MA, Thoeringer CK, Huber HP, Holzer P (2007) Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience 150: 522-536.

236. Thoeringer CK, Wultsch T, Shahbazian A, Painsipp E, Holzer (2007) Multidrug-resistance gene 1-type p-glycoprotein (MDR1 p-gp) inhibition by tariquidar impacts on neuroendocrine and behavioral processing of stress. Psychoneuroendocrinology 32: 1028-1040.

235. Seerden TC, De Man JG, Holzer P, Van den Bossche RM, Herman AG, Pelckmans PA, De Winter BY (2007) Experimental pancreatitis disturbs gastrointestinal and colonic motility in mice: effect of the prokinetic tegaserod. Neurogastroenterol Motil 19: 856-864.

234. Herbert MK, Weis R, Holzer P (2007) The enantiomers of tramadol and its major metabolite inhibit peristalsis in the guinea pig small intestine via differential mechanisms. BMC Pharmacol 7:5.

233. Holzer P, Wultsch T, Edelsbrunner M, Mitrovic M, Shahbazian A, Painsipp E, Bock E, Pabst MA (2007) Increase in gastric acid-induced afferent input to the brainstem in mice with gastritis. Neuroscience 145:1108-1119.

232. Holzer P (2007) Treatment of opioid-induced gut dysfunction. Expert Opin Investig Drugs 16:181-194.

231. Shahbazian A, Petkov V, Baykuscheva-Gentscheva T, Hoeger H, Painsipp E, Holzer P, Mosgoeller W (2007) Involvement of endothelial NO in the dilator effect of VIP on rat isolated pulmonary artery. Regul Pept 139:102-108.

230. Holzer P (2007) Taste Receptors in the Gastrointestinal Tract. V. Acid sensing in the gastrointestinal tract. Am. J. Gastroenterol. 292:G699-G705. (available online)

229. Fruhwald S, Holzer P, Metzler H (2007) Intestinal motility disturbances in intensive care patients pathogenesis and clinical impact. Intensive Care Med 33:36-44.

228. Holzer P (2001) Gastroduodenal mucosal defense: coordination by a network of messengers and mediators. Curr Opin Gastroenterol 17:489-496.

227. Holzer P (2000) Gastroduodenal mucosal defense. Curr Opin Gastroenterol 16:469-478.

226. Holzer P (2006) Efferent-like roles of afferent neurons in the gut: blood flow regulation and tissue protection. Auton Neurosci 125:70-75.

225. Wultsch T, Painsipp E, Donner S, Sperk G, Herzog H, Peskar BA, Holzer P (2006) Selective increase of dark phase water intake in neuropeptide-Y Y2 and Y4 receptor knockout mice. Behav Brain Res 168:255-260.

224. Wultsch T, Painsipp E, Thoeringer CK, Herzog H, Sperk G, Holzer P (2005) Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors. Neuroscience 136:1097-1107.

223. Holzer P, Painsipp E (2005) Der Darm - ein Organ für die Psychiatrie? ClinicumPsy 1:30-34.

222. Holzer P, Painsipp E, Schuligoi R (2005) Differential effects of intragastric acid and capsaicin on gastric emptying and afferent input to the rat spinal cord and brainstem. BMC Neurosci 6:60.

221. Römer M, Painsipp E, Schwetz I, Holzer P (2005) Facilitation of gastric compliance and cardiovascular reaction by repeated isobaric distension of the rat stomach. Neurogastroenterol Motil 17:399-409.

220. Herbert MK, Weis R, Holzer P, Roewer N (2005) Peristalsis in the guinea pig small intestine in vitro is impaired by acetaminophen but not aspirin and dipyrone. Anesth Analg 100:120-127.

219. P. Holzer: Vanilloid receptor TRPV1: hot on the tongue and inflaming the colon. Neurogastroenterol. Motil. 16, 697-699 (2004)

218. P. Holzer, M. Danzer, R. Schicho, C. Samberger, E. Painsipp, and I.T. Lippe: Vagal afferent input from the acid-challenged rat stomach to the brainstem: enhancement by interleukin-1beta. Neuroscience 129, 439-445 (2004)

217. S. Fruhwald, E. Herk, H.F. Hammer, P. Holzer, and H. Metzler: Differential reversal of drug-induced small bowel paralysis by cerulein and neostigmine. Intensive Care Med. 30, 1414-1420 (2004)

216. M.K. Herbert and P. Holzer: Innovative treatment of acute migraine pain with CGRP receptor antagonists. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 39, 657-661 (2004)

214. P. Holzer: Viszerale Schmerzen: Funktionelle Dyspepsie. MedReport Nr. A7, 28. Jahrgang, 4-5 (2004)

213. P. Holzer: TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia. Eur. J. Pharmacol. 500, 231-241 (2004)

212. L. Barthó, R. Benkó, R. Patacchini, G. Pethö, U. Holzer-Petsche, P. Holzer, Z. Lázár, S. Undi, L. Illényi, A. Antal, and ö.P. Horváth: Effects of capsaicin on visceral smooth muscle: a valuable tool for sensory neurotransmitter identification. Eur. J. Pharmacol. 500, 143-157 (2004)

211. B. Schmidt, J. Hammer, P. Holzer, and H.F. Hammer: Chemical nociception in the jejunum induced by capsaicin. Gut 53, 1109-1116 (2004)

210. S. Fruhwald, E. Herk, G. Schöll, A. Shahbazian, H.F. Hammer, H. Metzler, and P. Holzer: Endotoxin pretreatment modifies peristalsis and attenuates the antipropulsive action of adrenoceptor agonists in the guinea-pig small intestine. Neurogastroenterol. Motil. 16, 213-222 (2004)

209. R. Schicho, W. Florian, I. Liebmann, P. Holzer, and I.T. Lippe: Increased expression of TRPV1 receptor in dorsal root ganglia by acid insult of the rat gastric mucosa. Eur. J. Neurosci. 19, 1811-1818 (2004)

208. P. Holzer: Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans. Neurosci. Lett. 361, 192-195 (2004)

207. P. Holzer: Gastrointestinal pain in functional bowel disorders: sensory neurons as novel drug targets. Expert Opin. Ther. Targets 8, 107-123 (2004)

206. R. Schicho, P. Holzer, and I.T. Lippe: Gastric enteric neurones that respond to luminal injury. Neurogastroenterol. Motil. 16 (Suppl. 1), 129-132 (2004)

205. R. Patacchini, A. Lecci, P. Holzer, and C.A. Maggi: Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature. Trends Pharmacol. Sci. 25, 1-3 (2004)

204. M. Danzer, M. Jocic, C. Samberger, E. Painsipp, E. Bock, M.-A. Pabst, K. Crailsheim, R. Schicho, I.T. Lippe, and P. Holzer: Stomach-brain communication by vagal afferents in response to luminal acid backdiffusion, gastrin, and gastric acid secretion. Am. J. Physiol. 286, G403-G411 (2004)

203. M. Danzer, C. Samberger, R. Schicho, I.T. Lippe, and P. Holzer: Immunocytochemical characterization of rat brainstem neurons with vagal afferent input from the stomach challenged by acid or ammonia. Eur. J. Neurosci. 19, 85-92 (2004)

202. K. Gharzouli and P. Holzer: Inhibition of guinea-pig intestinal peristalsis by the flavonoids quercetin, naringenin, apigenin and genistein. Pharmacology 70, 5-14 (2004)

201. P. Holzer: Afferent signalling of gastric acid challenge. J. Physiol. Pharmacol. 54 Suppl. 4, 43-53 (2003)

200. P. Holzer: Acid-sensitive ion channels in gastrointestinal function. Curr. Opin. Pharmacol. 3, 618-625 (2003)

199. P. Holzer, A. Shahbazian, E. Painsipp, and A. Heinemann: Evaluation of peristalsis in multiple segments of the guinea-pig isolated small intestine: optimisation of tissue use by refined in vitro methodology. Altern. Lab. Anim. 31, 419-427 (2003)

198. Zs. Lázár, R. Benkó, K. Bölcskei, Z. Rumbus, M. Wolf, P. Holzer, C.A. Maggi, and L. Barthó: Actions of endothelin and corticotropin releasing factor in the guinea-pig ileum: no evidence for an interaction with capsaicin-sensitive neurons. Neuropeptides 37, 220-232 (2003)

197. P. Holzer, E. Painsipp, M. Jocič, and Á. Heinemann: Acid challenge delays gastric pressure adaptation, blocks gastric emptying and stimulates gastric fluid secretion in the rat. Neurogastroenterol. Motil. 15, 45-55 (2003)

196. R. Schicho, M. Schemann, M.A. Pabst, P. Holzer, and I.T. Lippe: Capsaicin-sensitive extrinsic afferents are involved in acid-induced activation of distinct myenteric neurons in the rat stomach. Neurogastroenterol. Motil. 15, 33-44 (2003)

195. M.K. Herbert, W. Berg, A. Kublik, P. Holzer, and N. Roewer: Thio- and oxybarbiturates inhibit peristalsis in the guinea-pig ileum in vitro. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 37, 721-726 (2002)

194. P. Holzer, R. Schicho and I.T. Lippe: The enteric nervous system - a brain in the gut. Neuroforum 3/02, 218-226 (2002)

193. A. Shahbazian, Á. Heinemann, B.A. Peskar, and P. Holzer: Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine. Br. J. Pharmacol. 137, 1047-1054 (2002)

192. M.K. Herbert, S. Roth-Goldbrunner, P. Holzer, and N. Roewer: Clonidine and dexmedetomidine potently inhibit peristalsis in the guinea pig ileum in vitro. Anesthesiology 97, 1491-1499 (2002)

191. Á. Heinemann, D. Pieber, and P. Holzer: Inhibition by female sex steroids of peristalsis in the guinea-pig small intestine. Digestion 65, 213-219 (2002)

190. P. Holzer: Sensory neuron responses to mucosal noxae in the upper gut: relevance to mucosal integrity and gastrointestinal pain. Neurogastroenterol. Motil. 14, 459-475 (2002)

189. M.K. Herbert and P. Holzer: Neurogenic inflammation. II. Pathophysiology and clinical implications. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 37, 386-394 (2002)

188. M.K. Herbert and P. Holzer: Neurogenic inflammation. I. Basic mechanisms, physiology and pharmacology. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 37, 314-325 (2002)

187. M.K. Herbert and P. Holzer: Warum versagen Substanz P (NK1)-Rezeptorantagonisten in der Schmerztherapie? Anaesthesist 51, 308-319 (2002)

186. A. Shahbazian, Á. Heinemann, H. Schmidhammer, E. Beubler, U. Holzer-Petsche, and P. Holzer: Involvement of μ- and κ-, but not δ-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine. Br. J. Pharmacol. 135, 741-750 (2002)

185. S. Fruhwald, E. Herk, T. Petnehazy, S. Scheidl, P. Holzer, H.F. Hammer, and H. Metzler: Sufentanil potentiates the inhibitory effect of epinephrine on intestinal motility. Intensive Care Med. 28, 74-80 (2002)

184. P. Holzer: Capsaicin-sensitive afferent neurons in the GI tract. Medical Tribune Japan 12, 20-23, 2001

183. P. Holzer, M. Jocič, F. Cabre, and D. Mauleon: Estimation of acute flurbiprofen and ketoprofen toxicity in rat gastric mucosa at therapy-relevant doses. Inflammation Research 50, 602-608 (2001)

182. T. Michl, M. Jocič, R. Schuligoi, and P. Holzer: Role of tachykinin receptors in the central processing of afferent input from the acid-threatened rat stomach. Regul. Pept. 102, 119 -126 (2001)

181. Z. Lazar, A. Shahbazian, R. Benko, G. Toth, B. Penke, L. Barthó, and P. Holzer: PACAP-(6-38) inhibits the effects of vasoactive intestinal polypeptide, but not PACAP, on the small intestinal circular muscle. Eur. J. Pharmacol. 431, 259-264 (2001)

180. R. Schicho, M. Schemann, P. Holzer, and I.T. Lippe: Mucosal acid challenge activates nitrergic neurons in the myenteric plexus of the rat stomach. Am. J. Physiol. 281, G1316-G1321 (2001)

179. T. Michl, M. Jocič, Á. Heinemann, R. Schuligoi, and P. Holzer: Vagal afferent signaling of a gastric mucosal acid insult to medullary, pontine, thalamic, hypothalamic and limbic, but not cortical, nuclei of the rat brain. Pain 92, 19-27 (2001)

178. A. Shahbazian, R. Schuligoi, Á. Heinemann, B.A. Peskar, and P. Holzer: Disturbance of peristalsis in the guinea-pig isolated small intestine by indomethacin, but not cyclo-oxygenase isoform-selective inhibitors. Br. J. Pharmacol. 132, 1299-1309 (2001)

177. P. Holzer and E. Painsipp: Differential effects of clonidine, dopamine, dobutamine, and dopexamine on basal and acid-stimulated mucosal blood flow in the rat stomach. Critical Care Med. 29, 335-343 (2001)

176. M. Jocič, R. Schuligoi, E. Schöninkle, M.A. Pabst, and P. Holzer: Cooperation of NMDA and tachykinin NK1 and NK2 receptors in the medullary transmission of vagal afferent input from the acid-threatened rat stomach. Pain 89, 147-157 (2001)

175. P. Holzer: Inflammation and gut hypersensitivity: peripheral mechanisms. Gastroenterol. Int. 14, 32-45 (2001)

174. P. Holzer, T. Michl, M. Danzer, M. Jocič, R. Schicho, and I.T. Lippe: Surveillance of the gastrointestinal mucosa by sensory neurons. J. Physiol. Pharmacol. 52, 505-521 (2001)

173. P. Holzer: Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain. Eur. J. Pharmacol. 429, 177-193 (2001)

172. P. Holzer, R. Schicho, U. Holzer-Petsche, and I.T. Lippe: The gut as a neurological organ. Wiener Klin. Wochenschr. 113, 647-660 (2001)

171. P. Holzer: Gastroduodenal mucosal defense: coordination by a network of messengers and mediators. Current Opinion in Gastroenterology 17, 489-496 (2001)

170. P. Holzer and U. Holzer-Petsche: Tachykinin receptors in the gut: physiological and pathological implications. Current Opinion in Pharmacology 1: 583-590 (2001)

169. P. Holzer: Gastroduodenal mucosal defense. Current Opinion in Gastroenterology 16, 469-478 (2000)

168. P. Holzer: Local microcirculatory reflexes and afferent signalling in response to gastric acid challenge. Gut 47 (Suppl. IV), iv48-iv48 (2000)

166. R. Patacchini, C.A. Maggi, and P. Holzer: Tachykinin autoreceptors in the gut. Trends Pharmacol. Sci. 21, 166 (2000)

165. S. Fruhwald, S. Scheidl, W. Toller, T. Petnehazy, P. Holzer, H. Metzler, and H.F. Hammer: Low potential of dobutamine and dopexamine to block intestinal peristalsis as compared with other catecholamines. Critical Care Med. 28, 2893-2897 (2000)

164. A. Shahbazian and P. Holzer: Regulation of guinea pig intestinal peristalsis by endogenous endothelin acting at ETB receptors. Gastroenterology 119, 80-88 (2000)

163. A. Shahbazian and P. Holzer: Differences in circular muscle contraction and peristaltic motor inhibition caused by tachykinin NK1 receptor agonists in the guinea-pig small intestine. Neurogastroenterol. Mot. 12, 197-204 (2000)

162. Á. Heinemann and P. Holzer: Intestinal motor depression by 7-nitroindazole through an action unrelated to nitric oxide synthase inhibition. Pharmacology 59, 310-320 (1999)

161. Á. Heinemann, A. Shahbazian, L. Barthó, and P. Holzer: Different receptors mediating the inhibitory action of exogenous ATP and endogenously released purines on guinea-pig intestinal peristalsis. Br. J. Pharmacol. 128, 313-320 (1999)

160. F. Akar, B.S. Uydes-Dogan, C.K. Buharalioglu, G. Abban, Á. Heinemann, P. Holzer, and J. Van de Voorde: Protective effect of cromakalim and diazoxide, and proulcerogenic effect of glibenclamide on indomethacin-induced gastric injury. Eur. J. Pharmacol. 374, 461-470 (1999)

159. Á. Heinemann, A. Shahbazian, and P. Holzer: Cannabinoid inhibition of guinea-pig intestinal peristalsis via inhibition of excitatory and activation of inhibitory neural pathways. Neuropharmacology 38, 1289-1297 (1999)

158. Á. Heinemann and P. Holzer: Stimulant action of pituitary adenylate cyclase-activating peptide on normal and drug-compromised peristalsis in the guinea-pig intestine. Br. J. Pharmacol. 127, 763-771 (1999)

157. Á. Heinemann, V. Sattler, M. Jocič, W. Wienen, and P. Holzer: Effect of angiotensin II and telmisartan, an angiotensin1 receptor antagonist, on rat gastric mucosal blood flow. Aliment. Pharmacol. Ther. 13, 347-355 (1999)

156. L. Barthó, L. Lenard, R. Patacchini, V. Halmai, M. Wilhelm, P. Holzer, and C.A. Maggi: Tachykinin receptors are involved in the "local efferent" motor response to capsaicin in the guinea-pig small intestine and oesophagus. Neuroscience 90, 221-228 (1999)

155. P. Holzer and M.A. Pabst: Visceral afferent neurons: role in gastric mucosal protection. News Physiol. Sci. 14, 201-206 (1999)

154. P. Holzer: Gastric mucosal protection signalled by peptidergic afferent neurons. Drug News & Perspectives 12, 463-472 (1999)

153. P. Holzer: Tachykinins as targets of gastroenterological pharmacotherapy. Drug News & Perspectives 11, 394-401 (1998)

152. Á. Heinemann, G. Horina, R.E. Stauber, C. Pertl, P. Holzer, and B.A. Peskar: Lack of effect of a selective vasopressin V1A receptor antagonist, SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed. Br. J. Pharmacol. 125, 1120-1127 (1998)

151. R. Schuligoi, M. Jocič, Á. Heinemann, E. Schöninkle, M.A. Pabst, and P. Holzer: Gastric acid-evoked c-fos messenger RNA expression in rat brainstem is signaled by capsaicin-resistant vagal afferents. Gastroenterology 115, 649-660 (1998)

150. J. Hammer, H.F. Hammer, A.J. Eherer, W. Petritsch, P. Holzer, and G.J. Krejs: Intraluminal capsaicin does not affect fluid and electrolyte absorption in the human jejunum but does cause pain. Gut 43, 252-255 (1998)

149. Á. Heinemann, C.H. Wachter, and P. Holzer: Differential regulation of mesenteric and femoral blood flow in the rat as revealed by computerized data acquisition and evaluation. J. Auton. Pharmacol. 18, 39-48 (1998)

148. C.H. Wachter, Á. Heinemann, J. Donnerer, M.A. Pabst, and P. Holzer: Mediation by 5-hydroxytryptamine of the femoral vasoconstriction induced by acid challenge of the rat gastric mucosa. J. Physiol. (London) 509, 541-550 (1998)

147. P. Holzer, I.T. Lippe, Á. Heinemann, and L. Barthó: Tachykinin NK1 and NK2 receptor-mediated control of peristaltic propulsion in the guinea-pig small intestine in vitro. Neuropharmacology 37, 131-138 (1998)

146. P. Holzer: Implications of tachykinins and calcitonin gene-related peptide in inflammatory bowel disease. Digestion 59, 269-283 (1998)

145. P. Holzer: Neural injury, repair, and adaptation in the GI tract. II. The elusive action of capsaicin on the vagus nerve. Am. J. Physiol. 275, G8-G13 (1998)

144. P. Holzer and C.A. Maggi: Dissociation of dorsal root ganglion neurons into afferent and efferent-like neurons. Neuroscience 86, 389-398 (1998)

143. P. Holzer: Neural emergency system in the stomach. Gastroenterology 114, 823-839 (1998)
[1998-2002 (SCI): 51 citations]

142. P. Holzer: Neurogenic vasodilatation and plasma leakage in the skin. Gen. Pharmacol. 30, 5-11 (1998)
[1998-2002 (SCI): 66 citations]

141. P. Holzer and U. Holzer-Petsche: Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol. Ther. 73, 219-263 (1997)
[1997-2002 (SCI): 82 citations]

140. P. Holzer and U. Holzer-Petsche: Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol. Ther. 73, 173-217 (1997)
[1997-2002 (SCI): 107 citations]

139. Á. Heinemann, V. Sattler, M. Jocič, and P. Holzer: Inhibition of acid-induced hyperaemia in the rat stomach by endogenous NK2 receptor ligands. Neurosci. Lett. 237, 133-135 (1997)

138. Á. Heinemann, C.H. Wachter, B.A. Peskar, and P. Holzer: Dilatation by angiotensin II of the rat femoral arterial bed in vivo via pressure/flow-induced release of nitric oxide and prostaglandins. Br. J. Pharmacol. 122, 975-984 (1997)

137. A. Mendez, M. Casadevall, C.H. Wachter, J.I. Elizalde, M. del Rivero, Á. Heinemann, P. Holzer, E. Quintero, and J.M. Piqué: Gastric mucosal blood flow regulation in response to different stimuli. Digest. Dis. Sci. 42, 1873-1879 (1997)

136. P. Holzer: Involvement of nitric oxide in the substance P-induced inhibition of intestinal peristalsis. NeuroReport 8, 2857-2860 (1997)

135. Á. Heinemann, C. Wachter, P. Holzer, P. Fickert, and R. Stauber: Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric vessels of portal hypertensive rats. Br. J. Pharmacol. 121, 1031-1037 (1997)

134. I.T. Lippe, C.H. Wachter and P. Holzer: Neurokinin A-induced vasoconstriction and muscular contraction in the rat isolated stomach: mediation by distinct and unusual neurokinin2 receptors. J. Pharmacol. Exp. Ther. 281, 1294-1302 (1997)

133. P. Holzer, I.T. Lippe, A. Lotfi Tabrizi, L. Lenard, and L. Barthó: Dual excitatory and inhibitory effect of nitric oxide on peristalsis in the guinea pig intestine. J. Pharmacol. Exp. Ther. 280, 154-161 (1997)

132. Á. Heinemann, M. Jocič, G. Herzeg, and P. Holzer: Tachykinin inhibition of acid-induced gastric hyperaemia in the rat. Br. J. Pharmacol. 119, 1525-1532 (1996)

131. R. Schuligoi, G. Herzeg, C. Wachter, M. Jocič, and P. Holzer: Differential expression of c-fos messenger RNA in the rat spinal cord after mucosal and serosal irritation of the stomach. Neuroscience 72, 535-544 (1996)

130. Á. Heinemann, M. Jocič, B.M. Peskar, and P. Holzer: CCK-evoked hyperemia in rat gastric mucosa involves neural mechanisms and nitric oxide. Am. J. Physiol. 270, G253-G258 (1996)

129. M.A. Pabst, Ch. Wachter, and P. Holzer: Morphologic basis of the functional gastric acid barrier. Lab. Invest. 74, 78-85 (1996)

128. P. Holzer, Ch. Wachter, Á. Heinemann, M. Jocič, I.T. Lippe, and M.K. Herbert: Diverse interactions of calcitonin gene related peptide and nitric oxide in the gastric and cutaneous microcirculation. Can. J. Physiol. Pharmacol. 73, 991-994 (1995)

127. P. Holzer, Ch. Wachter, Á. Heinemann, M. Jocič, I.T. Lippe, and M.K. Herbert: Sensory nerves, nitric oxide and NANC vasodilatation. Arch. Int. Pharmacodyn. Ther. 329, 67-79 (1995)

126. L. Barthó and P. Holzer: The inhibitory modulation of guinea-pig intestinal peristalsis caused by capsaicin involves calcitonin gene-related peptide and nitric oxide. Naunyn-Schmiedeberg's Arch. Pharmacol. 353, 102-109 (1995)

125. M.C.H. Haeusler, M.E. Hoellwarth, and P. Holzer: Paralytic ileus in fetus-neonate after maternal intake of benzodiazepine. Prenatal Diagnosis 15, 1165-1167 (1995)

124. P. Holzer, M. Jocič and B.A. Peskar: Mediation by prostaglandins of the nitric oxide-induced neurogenic vasodilatation in rat skin. Br. J. Pharmacol. 116, 2365-2370 (1995)

123. Ch. Wachter, Á. Heinemann, and P. Holzer: Dilator effect of the angiotensin II antagonist telmisartan on the gastric, but not femoral, arterial bed of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 352, 691-694 (1995)

122. Á. Heinemann, M. Jocič, U. Holzer-Petsche, G. Pethö, B.M. Peskar, D.C. Horwell, and P. Holzer: Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa. Br. J. Pharmacol. 116, 2274-2278 (1995)

121. M.K. Herbert, S. Hering, and P. Holzer: Interleukin-1β, but not tumor necrosis factor, enhances neurogenic vasodilatation in the rat skin: involvement of nitric oxide. Can. J. Physiol. Pharmacol. 73, 1075-1079 (1995)

120. R. Amann, R. Schuligoi, P. Holzer, and J. Donnerer: The non-peptide NK1 receptor antagonist SR140333 produces long-lasting inhibition of neurogenic inflammation, but does not influence acute chemo- or thermonociception in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 352, 201-205 (1995)

119. P. Holzer, W. Schluet, and C.A. Maggi: Substance P stimulates and inhibits intestinal peristalsis via distinct receptors. J. Pharmacol. Exp. Ther. 274, 322-328 (1995)

118. Ch. Wachter, Á. Heinemann, M. Jocič, and P. Holzer: Visceral vasodilatation and somatic vasoconstriction evoked by acid challenge of the rat gastric mucosa: diversity of mechanisms. J. Physiol. (London) 486, 505-516 (1995)

117. R. Patacchini, L. Barthó, P. Holzer, and C.A. Maggi: Activity of SR 142801 at peripheral tachykinin receptors. Eur. J. Pharmacol. 278, 17-25 (1995)

116. M. Fernandez, M. Casadevall, R. Schuligoi, P. Pizcueta, J. Panes, M.D. Barrachina, J. Donnerer, J.M. Pique, J.V. Esplugues, J. Bosch, J. Rodes, and P. Holzer: Neonatal capsaicin treatment does not prevent the splanchnic vasodilatation in portal hypertensive rats. Hepatology 20, 1609-1614 (1994)

115. P. Holzer, Ch. Wachter, M. Jocič, and Á. Heinemann: Vascular bed-dependent roles of the peptide CGRP and nitric oxide in acid-evoked hyperaemia of the rat stomach. J. Physiol. (London) 480, 575-585 (1994)

114. C.A. Maggi, P. Holzer, and S. Giuliani: Effect of ω-conotoxin on cholinergic and tachykininergic excitatory neurotransmission to the circular muscle of the guinea-pig colon. Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 529-536 (1994)

113. G. Pethö, M. Jocič, and P. Holzer: Role of bradykinin in the hyperaemia following acid challenge of the rat gastric mucosa. Br. J. Pharmacol. 113, 1036-1042 (1994)

112. M.K. Herbert and P. Holzer: Nitric oxide mediates the amplification by interleukin-1β of neurogenic vasodilatation in the rat skin. Eur. J. Pharmacol. 260, 89-93 (1994)

111. P. Holzer and M. Jocič: Cutaneous vasodilatation induced by nitric oxide-evoked stimulation of afferent nerves in the rat. Br. J. Pharmacol. 112, 1181-1187 (1994)

110. C.A. Maggi, R. Patacchini, L. Barthó, P. Holzer, and P. Santicioli: Tachykinin NK1 and NK2 receptor antagonists and atropine-resistant ascending excitatory reflex to the circular muscle of the guinea-pig ileum. Br. J. Pharmacol. 112, 161-168 (1994)

109. H.N. Doods, M. Entzeroth, H. Ziegler, N. Mayer, and P. Holzer: Pharmacological profile of selective muscarinic receptor antagonists on guinea-pig ileal smooth muscle. Eur. J. Pharmacol. 253, 275-281 (1994)

108. M.K. Herbert and P. Holzer: Interleukin-1β enhances capsaicin-induced neurogenic vasodilatation in the rat skin. Br. J. Pharmacol. 111, 681-686 (1994)

107. P. Holzer and C.A. Maggi: Synergistic role of muscarinic acetylcholine and tachykinin NK-2 receptors in intestinal peristalsis. Naunyn-Schmiedeberg's Arch. Pharmacol. 349, 194-201 (1994)

106. I.T. Lippe, W. Sametz, K. Sabin, and P. Holzer: Inhibitory role of capsaicin-sensitive afferent neurons and nitric oxide in hemostasis. Am. J. Physiol. 265, H1864-H1868 (1993)

105. B.M. Peskar, H.C. Wong, J.H. Walsh, and P. Holzer: A monoclonal antibody to calcitonin gene-related peptide abolishes capsaicin-induced gastroprotection. Eur. J. Pharmacol. 250, 201-203 (1993)

104. M. Battistel, M. Plebani, F. Di Mario, M. Jocič, I.T. Lippe, and P. Holzer: Chronic nicotine intake causes vascular dysregulation in the rat gastric mucosa. Gut 34, 1688-1692 (1993)

103. P. Holzer and M.A. Pabst: A histological and functional study of the effects of acid and capsaicin on ethanol-induced damage in the rat gastric mucosa. Surg. Res. Commun. 14, 1-12 (1993)

102. P. Holzer, I.T. Lippe, M. Jocič, Ch. Wachter, R. Erb, and Á. Heinemann: Nitric oxide-dependent and -independent hyperaemia due to calcitonin gene-related peptide in the rat stomach. Br. J. Pharmacol. 110, 404-410 (1993)

101. P. Holzer and C.A. Maggi: Stimulation and propagation of the ascending enteric reflex contraction: role of tachykinins and acetylcholine. Regul. Pept. 46, 383-385 (1993)

100. E.H. Livingston and P. Holzer: Gastric hyperemia accompanying acid secretion is not mediated by sensory nerves. Digest. Dis. Sci. 38, 1190-1194 (1993)

99. M. A. Pabst, E. Schöninkle, and P. Holzer: Ablation of capsaicin sensitive afferent nerves impairs defence but not rapid repair of rat gastric mucosa. Gut 34, 897-903 (1993)

98. I.T. Lippe, A. Stabentheiner, and P. Holzer: Role of nitric oxide in the vasodilator but not exudative component of mustard oil-induced inflammmation in rat skin. Agents Actions 38, C22-C24 (1993)

97. H.C. Wong, Y. Taché, K.C.K. Lloyd, H. Yang, C. Sternini, P. Holzer, and J.H. Walsh: Monoclonal antibody to rat α-CGRP: production, characterization, and in vivo immunoneutralization activity. Hybridoma 12, 93-106 (1993)

96. I.T. Lippe, A. Stabentheiner, and P. Holzer: Participation of nitric oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin. Eur. J. Pharmacol. 232, 113-120 (1993)

95. P. Holzer, W. Schluet, and C.A. Maggi: Ascending enteric reflex contraction: roles of acetylcholine and tachykinins in relation to distension and propagation of excitation. J. Pharmacol. Exp. Ther. 264, 391-396 (1993)

94. P. Holzer: Reflex gastric motor inhibition caused by intraperitoneal bradykinin: antagonism by Hoe 140, a bradykinin antagonist. Peptides 13, 1073-1077 (1992)

93. P. Holzer, I.T. Lippe, and R. Amann: Participation of capsaicin-sensitive afferent neurons in gastric motor inhibition caused by laparotomy and intraperitoneal acid. Neuroscience 48, 715-722 (1992)

92. H.E. Raybould, C. Sternini, V.E. Eysselein, M. Yoneda, and P. Holzer: Selective ablation of spinal afferent neurons containing CGRP attenuates gastric hyperemic response to acid. Peptides 13, 249-254 (1992)

91. P. Holzer and I.T. Lippe: Gastric mucosal hyperemia due to acid back-diffusion depends on splanchnic nerve activity. Am. J. Physiol. 262, G505-G509 (1992)

90. I.T. Lippe and P. Holzer: Participation of endothelium-derived nitric oxide but not prostacyclin in the gastric mucosal hyperaemia due to acid back-diffusion. Br. J. Pharmacol. 105, 708-714 (1992)

89. P. Holzer: Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev. Physiol. Biochem. Pharmacol. 121, 49-146 (1992)
[1992-2002 (SCI): 122 citations]

88. P. Holzer: Neural emergency system in the stomach: peptidergic neurons signal for protective hyperemia. Regul. Pept. Lett. IV, 48-51 (1992)

87. L. Barthó, G. Koczan, P. Holzer, C.A. Maggi, and J. Szolcsányi: Antagonism of the motor effects of CGRP and of capsaicin on the guinea pig ileum by human CGRP8-37. Ann. New York Acad. Sci. 657, 538-540 (1992)

86. P. Holzer and I.T. Lippe: Role of calcitonin gene-related peptide in gastrointestinal blood flow. Ann. New York Acad. Sci. 657, 228-239 (1992)

85. P. Holzer, I.T. Lippe, H.E. Raybould, M.A. Pabst, E.H. Livingston, R. Amann, B.M. Peskar, B.A. Peskar, Y. Taché und P.H. Guth: Role of peptidergic sensory neurons in gastric mucosal blood flow and protection. Ann. New York Acad. Sci. 632, 272-282 (1991)

84. P. Holzer: Capsaicin: cellular targets, mechanisms of action and selectivity for thin sensory neurons. Pharmacol. Rev. 43, 143-201 (1991)
[1991-2002 (SCI): 958 citations]

83. L. Barthó, G. Koczan, P. Holzer, C.A. Maggi, and J. Szolcsányi: Antagonism of the effects of calcitonin gene-related peptide and of capsaicin on the guinea-pig isolated ileum by human α-calcitonin gene-related peptide(8-37). Neurosci. Lett. 129, 156-159 (1991)

82. P. Holzer, E.H. Livingston, and P.H. Guth: Sensory neurons signal for an increase in rat gastric mucosal blood flow in the face of pending acid injury. Gastroenterology 101, 416-423 (1991)

81. P. Holzer, E.H. Livingston, A. Saria, and P.H. Guth: Sensory neurons mediate protective vasodilatation in rat gastric mucosa. Am. J. Physiol. 260, G363-G370 (1991)
[1991-2002 (SCI): 124 citations]

80. P. Holzer and P.H. Guth: Neuropeptide control of rat gastric mucosal blood flow. Increase by CGRP and VIP, but not substance P and neurokinin A. Circ. Res. 68, 100-105 (1991)

79. V. Bauer, P. Holzer, and Y. Ito: Role of extra- and intracellular calcium in the contractile action of agonists in the guinea-pig ileum. Naunyn-Schmiedeberg's Arch. Pharmacol. 343, 58-64 (1991)

78. H.E. Raybould, P. Holzer, S.N. Reddy, H. Yang, and Y. Taché: Capsaicin-sensitive vagal afferents contribute to gastric acid and vascular responses to intracisternal TRH analog. Peptides 11, 789-795 (1990)

77. Y. Yonei, P. Holzer, and P.H. Guth: Laparotomy-induced gastric protection against ethanol injury is mediated by capsaicin-sensitive sensory neurons. Gastroenterology 99, 3-9 (1990)

76. P. Holzer, M.A. Pabst, I.T. Lippe, B.M. Peskar, B.A. Peskar, E.H. Livingston and P.H. Guth: Afferent nerve-mediated protection against deep mucosal damage in the rat stomach. Gastroenterology 98, 838-848 (1990)
[1990-2002 (SCI): 148 citations]

75. P. Holzer, B.M. Peskar, B.A. Peskar, and R. Amann: Release of calcitonin gene-related peptide induced by capsaicin in the vascularly perfused rat stomach. Neurosci. Lett. 108, 195-200 (1990)

74. P. Holzer: Nerves and gastric mucosal protection. Digest. Dis. Sci. 35, 1048-1049 (1990)

73. P. Holzer: Peppers, capsaicin, and the gastric mucosa. J. Am. Med. Assoc. 261, 3244 (1989)

72. P. Holzer, Ch. Pertl, and G. Wolf: Thyrotropin-releasing hormone potently modulates peristaltic motor activity of the guinea pig small intestine. J. Gastrointest. Motil. 1, 144-149 (1989)

71. I.T. Lippe, M. Lorbach, and P. Holzer: Close arterial infusion of calcitonin gene-related peptide into the rat stomach inhibits aspirin- and ethanol-induced hemorrhagic damage. Regul. Pept. 26, 35-46 (1989)

70. P. Holzer, M.A. Pabst, and I.T. Lippe: Intragastric capsaicin protects against aspirin-induced lesion formation and bleeding in the rat gastric mucosa. Gastroenterology 96, 1425-1433 (1989)

69. P. Holzer and I.T. Lippe: Protein kinase C may regulate the tonic component of intestinal smooth muscle contraction in response to substance P. Naunyn-Schmiedeberg's Arch. Pharmacol. 339, 214-220 (1989)

68. I.T. Lippe and P. Holzer: The diacylglycerol kinase inhibitor, R 59022, suppresses contractility of intestinal smooth muscle. Eur. J. Pharmacol. 159, 1-8 (1989)

67. P. Holzer, L. Barthó, O. Matusak, and V. Bauer: Calcitonin gene-related peptide action on intestinal circular muscle. Am. J. Physiol. 256, G546-G552 (1989)

66. P. Holzer: Ascending enteric reflex: multiple neurotransmitter systems and interactions. Am. J. Physiol. 256, G540-G545 (1989)

65. I.T. Lippe, M.A. Pabst, and P. Holzer: Intragastric capsaicin enhances rat gastric acid elimination and mucosal blood flow by afferent nerve stimulation. Br. J. Pharmacol. 96, 91-100 (1989)

64. L. Barthó, P. Holzer, S. Leander, and F. Lembeck: Evidence for an involvement of substance P, but not cholecystokinin-like peptides, in hexamethonium-resistant intestinal peristalsis. Neuroscience 28, 211-217 (1989)

63. P. Holzer and I.T. Lippe: Stimulation of afferent nerve endings by intragastric capsaicin protects against ethanol-induced damage of gastric mucosa. Neuroscience 27, 981-987 (1988)
[1988-2002 (SCI): 157 citations]

62. P. Holzer: Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24, 739-768 (1988)
[1988-2002 (SCI): 1108 citations]

61. P. Holzer, W. Schluet, I.T. Lippe, and W. Sametz: Involvement of capsaicin-sensitive sensory neurones in gastrointestinal function. Acta Physiol. Hung. 69, 403-411 (1987)

60. L. Barthó, P. Holzer, and F. Lembeck: Is ganglionic transmission through nicotinic receptors essential for the peristaltic reflex in the guinea-pig ileum? Neuropharmacology 26, 1663-1666 (1987)

59. L. Barthó, G. Pethö, A. Antal, P. Holzer, and J. Szolcsányi: Two types of relaxation due to capsaicin in the guinea pig isolated ileum. Neurosci. Lett. 81, 146-150 (1987)

58. P. Holzer, I.T. Lippe, L. Barthó, and A. Saria: Neuropeptide Y inhibits excitatory enteric neurons supplying the circular muscle of the guinea pig small intestine. Gastroenterology 92, 1944-1950 (1987)

57. P. Holzer, E. Beubler, R. Dirnhofer: Barbiturate poisoning and gastrointestinal propulsion. Arch. Toxicol. 60, 394-396 (1987)

56. L. Barthó, F. Lembeck, and P. Holzer: Calcitonin gene-related peptide is a potent relaxant of intestinal muscle. Eur. J. Pharmacol. 135, 449-452 (1987)

55. L. Barthó, P. Holzer, F. Lembeck, I.T. Lippe, and I. Setnikar: Evaluation of a new and potent cholecystokinin antagonist on motor responses of the guinea-pig intestine. Br. J. Pharmacol. 90, 753-761 (1987)

54. S.J. Bailey, I.T. Lippe, and P. Holzer: Effect of the tachykinin antagonist, (D-Pro4,D-Trp7,9,10)substance P-(4-11), on tachykinin- and histamine-induced inositol phosphate generation in intestinal smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 335, 296-300 (1987)

53. P. Holzer, L. Barthó, I.T. Lippe, W. Petritsch, and G. Leb: Effect of pancreatic polypeptide on the motility of the guinea-pig small intestine in vitro. Regul. Pept. 16, 305-314 (1986)

52. H. Kilbinger, P. Stauß, I. Erlhof, and P. Holzer: Antagonist discrimination between subtypes of substance P receptors in the guinea-pig ileum. Naunyn-Schmiedeberg's Arch. Pharmacol. 334, 181-187 (1986)

51. A. Bucsics, P. Holzer, I.T. Lippe, M.A. Pabst, and F. Lembeck: Density distribution of guinea pig myenteric plexus nerve endings containing immunoreactive substance P. Peptides 7, 761-765 (1986)

50. P. Holzer and W. Sametz: Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons. Gastroenterology 91, 975-981 (1986)
[1986-2002 (SCI): 197 citations]

49. P. Holzer, I.T. Lippe, and U. Holzer-Petsche: Inhibition of gastrointestinal transit due to surgical trauma or peritoneal irritation is reduced in capsaicin-treated rats. Gastroenterology 91, 360-363 (1986)

48. P. Holzer, U. Holzer-Petsche, and S. Leander: A tachykinin antagonist inhibits gastric emptying and gastrointestinal transit in the rat. Br. J. Pharmacol. 89, 453-459 (1986)

47. P. Holzer: Capsaicin-sensitive afferent neurones and gastrointestinal propulsion in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 332, 62-65 (1986)

46. L. Barthó and P. Holzer: Search for a physiological role of substance P in gastrointestinal motility. Neuroscience 16, 1-32 (1985)
[1985-2002 (SCI): 313 citations]

45. P. Holzer and I.T. Lippe: The inhibitory effect of neurotensin on the motor activity of rabbit ileum: dependence on the ionic environment. Eur. J. Pharmacol. 117, 329-335 (1985)

44. P. Holzer: Stimulation and inhibition of gastrointestinal propulsion induced by substance P and substance K in the rat. Br. J. Pharmacol. 86, 305-312 (1985)

43. P. Holzer and I.T. Lippe: Substance P action on phosphoinositides in guinea-pig intestinal muscle: a possible transduction mechanism? Naunyn-Schmiedeberg's Arch. Pharmacol. 329, 50-55 (1985)

42. J. Donnerer, D.K. Meyer, P. Holzer, and F. Lembeck: Release of cholecystokinin-immunoreactivity into the vascular bed of the guinea-pig small intestine during peristalsis. Naunyn-Schmiedeberg's Arch. Pharmacol. 328, 324-326 (1985)

41. J. Donnerer, P. Holzer, and F. Lembeck: Release of dynorphin, somatostatin and substance P from the vascularly perfused small intestine of the guinea-pig during peristalsis. Br. J. Pharmacol. 83, 919-925 (1984)

40. M. Holzbauer, J. Donnerer, P. Holzer, W. Schluet, F. Lembeck, and D.F. Sharman: Immunoreactive substance P in the tubero-hypophyseal system of the rat: selective decrease in the neural lobe after dehydration and sodium loading. Neurosci. Lett. 47, 23-28 (1984)

39. A. Gamillscheg, P. Holzer, J. Donnerer, and F. Lembeck: Effect of neonatal treatment with capsaicin on carrageenan-induced paw oedema in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 326, 340-342 (1984)

38. G. Zernig, P. Holzer, and F. Lembeck: A study of the mode and site of action of capsaicin in guinea-pig heart and rat uterus. Naunyn-Schmiedeberg's Arch. Pharmacol. 326, 58-63 (1984)

37. P. Holzer and I.T. Lippe: Substance P can contract the longitudinal muscle of the guinea-pig small intestine by releasing intracellular calcium. Br. J. Pharmacol. 82, 259-267 (1984)

36. J. Donnerer, L. Barthó, P. Holzer, and F. Lembeck: Intestinal peristalsis associated with release of immunoreactive substance P. Neuroscience 11, 913-918 (1984)

35. P. Holzer: Characterization of the stimulus-induced release of immunoreactive substance P from the myenteric plexus of the guinea-pig small intestine. Brain Res. 297, 127-136 (1984)

34. P. Holzer and G. Skofitsch: Release of endogenous 5-hydroxytryptamine from the myenteric plexus of the guinea-pig isolated small intestine. Br. J. Pharmacol. 81, 381-386 (1984)

33. P. Holzer: Substance P, the elusive peptide. Int. Med. 4, 24-26 (1984)

32. A. Bucsics, P. Holzer, and F. Lembeck: The substance P content of peripheral tissues in several mammals. Peptides 4, 451-455 (1983)

31. P. Holzer and U. Petsche: On the mechanism of contraction and desensitization induced by substance P in the intestinal muscle of the guinea-pig. J. Physiol. (London) 342, 549-568 (1983)

30. L. Barthó, P. Holzer, and F. Lembeck: Sympathetic control of substance P releasing enteric neurones in the guinea-pig ileum. Neurosci. Lett. 38, 291-296 (1983)

29. P. Holzer, I.T. Lippe, L. Barthó, and F. Lembeck: (D-Met2, Pro5) enkephalinamide and dynorphin-(1-13) inhibit the cholinergic contraction of the guinea-pig ileum induced by substance P. Eur. J. Pharmacol. 91, 83-88 (1983)

28. P. Holzer: Somatostatin - ein neues Therapeutikum der Gastroenterologie. Recipe 7, 3-4 (1982)

27. L. Barthó, P. Holzer, J. Donnerer, and F. Lembeck: Effects of substance P, cholecystokinin octapeptide, bombesin, and neurotensin on the peristaltic reflex of the guinea-pig ileum in the absence and in the presence of atropine. Naunyn-Schmiedeberg's Arch. Pharmacol. 321, 321-328 (1982)

26. L. Barthó, P. Holzer, F. Lembeck, and J. Szolcsányi: Evidence that the contractile response of the guinea-pig ileum to capsaicin is due to release of substance P. J. Physiol. (London) 332, 157-167 (1982)

25. P. Holzer, A. Bucsics, A. Saria, and F. Lembeck: A study of the concentrations of substance P and neurotensin in the gastrointestinal tract of various mammals. Neuroscience 7, 2919-2924 (1982)

24. L. Barthó, P. Holzer, J. Donnerer, and F. Lembeck: Evidence for the involvement of substance P in the atropine-resistant peristalsis of the guinea-pig ileum. Neurosci. Lett. 32, 69-74 (1982)

23. P. Holzer, A. Bucsics, and F. Lembeck: Distribution of capsaicin-sensitive nerve fibres containing immunoreactive substance P in cutaneous and visceral tissues of the rat. Neurosci. Lett. 31, 253-257 (1982)

22. P. Holzer: Different contractile effects of substance P on the intestine of mammals. Naunyn-Schmiedeberg's Arch. Pharmacol. 320, 217-220 (1982)

21. P. Holzer: An enquiry into the mechanism by which substance P facilitates the phasic longitudinal contractions of the rabbit ileum. J. Physiol. (London) 325, 377-392 (1982)

20. D.F. Sharman, P. Holzer, and M. Holzbauer: In vitro release of endogenous catecholamines from the neural and intermediate lobe of the hypophysis. Neuroendocrinology 34, 175-179 (1982)

19. G. Skofitsch, A. Saria, P. Holzer, and F. Lembeck: Histamine in tissue: determination by high-performance liquid chromatography after condensation with ortho-phthaldialdehyde. J. Chromat. 226, 53-59 (1981)

18. P. Holzer, A. Saria, G. Skofitsch, and F. Lembeck: Increase in tissue concentrations of histamine and 5-hydroxytryptamine following capsaicin treatment of newborn rats. Life Sci. 29, 1099-1105 (1981)

17. R. Gamse, S.E. Leeman, P. Holzer, and F. Lembeck: Differential effect of capsaicin on the content of somatostatin, substance P, and neurotensin in the nervous system of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 317, 140-148 (1981)

16. F. Erjavec, F. Lembeck, T. Florjanc-Irman, G. Skofitsch, J. Donnerer, A. Saria, and P. Holzer: Release of histamine by substance P. Naunyn-Schmiedeberg's Arch. Pharmacol. 317, 67-70 (1981)

15. P. Holzer, P.C. Emson, L.L. Iversen, and D.F. Sharman: Regional differences in the response to substance P of the longitudinal muscle and the concentration of substance P in the digestive tract of the guinea-pig. Neuroscience 6, 1433-1441 (1981)

14. P. Holzer, P.C. Emson, M. Holzbauer, L.L. Iversen, and D.F. Sharman: Tissue distribution of substance P in the domestic pig during postnatal development. Developmental Brain Res. 1, 455-459 (1981)

13. A.C. Cuello, R. Gamse, P. Holzer, and F. Lembeck: Substance P immunoreactive neurons following neonatal administration of capsaicin. Naunyn-Schmiedeberg's Arch. Pharmacol. 315, 185-194 (1981)

12. P. Holzer, F. Lembeck, and J. Donnerer: Caerulein, substance P, serotonin, and cholinomimetics induce rhythmic contractions of the intestinal circular muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 312, 131-137 (1980)

11. P. Holzer and F. Lembeck: Neurally mediated contraction of ileal longitudinal muscle by substance P. Neurosci. Lett. 17, 101-105 (1980)

10. P. Holzer, R. Gamse, and F. Lembeck: Distribution of substance P in the rat gastrointestinal tract - lack of effect of capsaicin pretreatment. Eur. J. Pharmacol. 61, 303-307 (1980)

9. R. Gamse, P. Holzer, and F. Lembeck: Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin. Br. J. Pharmacol. 68, 207-213 (1980)

8. F. Lembeck and P. Holzer: Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch. Pharmacol. 310, 175-183 (1979)
[1979-2002 (SCI): 983 citations]

7. P. Holzer and F. Lembeck: Longitudinal contraction of isolated guinea-pig ileum induced by rapid cooling. Naunyn-Schmiedeberg's Arch. Pharmacol. 310, 169-174 (1979)

6. P. Holzer, I. Jurna, R. Gamse, and F. Lembeck: Nociceptive threshold after neonatal capsaicin treatment. Eur. J. Pharmacol. 58, 511-514 (1979)

5. R. Gamse, P. Holzer, and F. Lembeck: Indirect evidence for presynaptic location of opiate receptors on chemosensitive primary sensory neurones. Naunyn-Schmiedeberg's Arch. Pharmacol. 308, 281-285 (1979)

4. P. Holzer and K. Hagmüller: Transient apnoea after systemic injection of GABA in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 308, 55-60 (1979)

3. P. Holzer and F. Lembeck: Effect of neuropeptides on the efficiency of the peristaltic reflex. Naunyn-Schmiedeberg's Arch. Pharmacol. 307, 257-264 (1979)

2. K. Hagmüller and P. Holzer: On the site of action of intravascular GABA on the respiration of the rat. Zool. Jb. Physiol. 82, 505-514 (1978)

1. F. Lembeck, P. Holzer, M. Schweditsch, and R. Gamse: Elimination of substance P from the circulation of the rat and its inhibition by bacitracin. Naunyn-Schmiedeberg's Arch. Pharmacol. 305, 9-16 (1978)

   Back to Top
Journal Articles Book Chapters Books, Whole Conference Proceedings Other Publications Invited Lectures

34. Holzer P (2011) Substance P. In: Kastin AJ (ed) Handbook of Biologically Active Peptides, Second Edition. Amsterdam: Elsevier (in press).

33. Holzer P (2011) Neural regulation of gastrointestinal blood flow. In: Johnson LR (ed) Physiology of the Gastrointestinal Tract, Fifth Edition. San Diego: Elsevier (in press).

32. Holzer P (2011) TRP channels in the gastrointestinal tract. In: Szallasi A (ed) TRP Channels in Health and Disease. Hauppauge, NY: Nova Science Publishers, 259-290.

31. Holzer P (2009) Acid-sensitive ion channels and receptors. In: Spina D, Canning B (eds) Pharmacology of Sensory Neurons. Handbook of Experimental Pharmacology, Volume 194. Berlin: Springer, 283-332.

30. Holzer P, Holzer-Petsche U (2009) Emerging pharmacological therapies. In: Giamberardino A (ed) Visceral Pain. Oxford: Oxford University Press, 51-61.

29. Holzer P (2008) The role of the vagus nerve in afferent signaling and homeostasis during visceral inflammation. In: Jancsó G (eds) Neurogenic Inflammation in Health and Disease. Neuroimmune Biology, Volume 8. Amsterdam: Elsevier, 321-338.

28. Holzer P (2007) Treating visceral pain via molecular targets on afferent neurons: current and future. In: Pasricha PJ, Willis WD, Gebhart GF (eds) Chronic Abdominal and Visceral Pain: Theory and Practice. New York: Informa Healthcare, 245-269.

27. Holzer P (2006) Substance P in the gastrointestinal tract. In: Kastin AJ (ed) Handbook of Biologically Active Peptides. Amsterdam: Elsevier, 1139-1145.

26. Holzer P (2006) Neural regulation of gastrointestinal blood flow. In: Johnson LR (ed) Physiology of the Gastrointestinal Tract, Fourth Edition. San Diego: Elsevier, 817-839.

25. Holzer P (2006) Tachykinin receptors. In: Watling KJ (ed) Sigma-RBI Handbook of Receptor Classification and Signal Transduction, 5th Edition. Natick: Sigma-RBI, 214-216.

24. Holzer P (2005) TRPV1 in gut function, abdominal pain and functional bowel disorders. In: Malmberg AB, Bley KR (eds) Turning Up the Heat on Pain: TRPV1 Receptors in Pain and Inflammation. Basel: Birkhäuser Verlag, Basel, 147-165.

23. P. Holzer: Tachykinin receptor antagonists: silencing neuropeptides with a role in the disturbed gut. In: Pathophysiology of the Enteric Nervous System: A Basis for Understanding Functional Diseases (R. Spiller and D. Grundy, eds.), Blackwell, Oxford, UK, pp. 212-227 (2004)

22. P. Holzer: Role of tachykinins in the gastrointestinal tract. In: Tachykinins. Handbook of Experimental Pharmacology, Volume 164 (P. Holzer, ed.), Springer, Berlin, Germany, pp. 511-558 (2004)

21. F. Lembeck, P. Holzer, and B.A. Peskar: Institut für Experimentelle und Klinische Pharmakologie, Medizinische Fakultät der Karl-Franzens-Universität Graz. In: Geschichte und Wirken der pharmakologischen, klinisch-pharmakologischen und toxikologischen Institute im deutschsprachigen Raum (A. Philippu, ed.), Berenkamp, Innsbruck, pp. 256-270 (2004)

20. P. Holzer: GI-CGRP (Calcitonin Gene-Related Peptide). In: Encyclopedia of Endocrine Diseases, Volume 2 (L. Martini, ed.), Elsevier Science, San Diego, California, USA, pp. 157-161 (2004)

19. P. Holzer: Calcitonin Gene-Related Peptide (CGRP). In: Encyclopedia of Gastroenterology (L.R. Johnson, ed.), Elsevier Science, San Diego, California, USA, pp. 241-247 (2004)

18. P. Holzer: Sensory neurons in gastrointestinal function In: Gut-Brain Peptides in the New Millenium. A Tribute to John Walsh by his Collaborators (Y. Taché, Y. Goto, G. Ohning, and T. Yamada, eds.), CURE Foundation, Los Angeles, CA, USA, pp. 275-284 (2002)

17. P. Holzer: Control of gastric functions by extrinsic sensory neurons. In: Innervation of the Gastrointestinal Tract (S. Brookes and M. Costa, eds.), Taylor & Francis, London and New York, pp. 103-170 (2002)

16. R. Amann and P. Holzer: Capsaicin and analogs. In: Experimental and Clinical Neurotoxicology, Second Edition (P.S. Spencer, H.H. Schaumburg, and A.C. Ludolph, eds.), Oxford University Press, New York, pp. 284-288 (2000)

15. P. Holzer: Tachykinins: from basic concepts to therapeutic implications. In: Drug Development: Molecular Targets for GI Diseases (T.S. Gaginella and A. Guglietta, eds.), Humana Press, Totowa, New Jersey, pp. 113-146 (2000)

14. P. Holzer: Basic aspects of capsaicin-sensitive afferent neurons in gastric mucosal protection. In: Capsaicin and Gastric Mucosal Defensive Mechanisms (H. Miwa and K. Takeuchi, eds.), Fujirebio, Tokyo, pp. 97-126 (1999)

13. P. Holzer: Neuropeptides and the gut: tachykinins and calcitonin gene-related peptide in intestinal inflammation and pain. In: Pain and Neurogenic Inflammation (S.D. Brain and P.K. Moore, eds.), Birkhäuser, Basel, pp. 225-244 (1999)

12. P. Holzer and U. Holzer-Petsche: Does neuropeptide substance P depress esophageal peristalsis? By which mechanisms? In: The Esophagogastric Junction (R. Giuli, J.-P. Galmiche, G.G. Jamieson, and C. Scarpignato, eds.), John Libbey Eurotext, Montrouge, pp. 128-134 (1998)

11. P. Holzer: Control of the cutaneous vascular system by afferent neurons. In: Autonomic Innervation of the Skin (J.L. Morris and I.L. Gibbins, eds.), Harwood, Amsterdam, pp. 213-267 (1997)

10. P. Holzer and L. Barthó: Sensory neurons in the intestine. In: Neurogenic Inflammation (P. Geppetti and P. Holzer, eds.), CRC Press, Boca Raton, pp. 153-167 (1996)

9. P. Holzer: Sensory neurons in the stomach. In: Neurogenic Inflammation (P. Geppetti and P. Holzer, eds.), CRC Press, Boca Raton, pp. 141-152 (1996)

8. P. Holzer, E.H. Livingston, and P.H. Guth: Neural, metabolic, physical, and endothelial factors in the regulation of the gastric circulation. In: Physiology of the Gastrointestinal Tract, Third Edition (L.R. Johnson, ed.), Raven Press, New York, pp. 1311-1329 (1994)

7. P. Holzer: Calcitonin gene-related peptide. In: Gut Peptides: Biochemistry and Physiology (J.H. Walsh and G.J. Dockray, eds.), Raven Press, New York, pp. 493-523 (1994)

6. P. Holzer: Capsaicin-sensitive nerves in the control of vascular effector mechanisms. In: Capsaicin in the Study of Pain (J.N. Wood, ed.), Academic Press, London, pp. 191-218 (1993)

5. P. Holzer: Peptidergic sensory neurons in the local regulation of splanchnic blood flow. In: Vascular Innervation and Receptor Mechanisms. New Perspectives (L. Edvinsson and R. Uddman, eds.), Academic Press, San Diego, pp. 299-321 (1993)

4. P. Holzer: Capsaicin: selective toxicity for thin primary afferent neurons. In: Handbook of Experimental Pharmacology, Volume 102: Selective Neurotoxicity (H. Herken, F. Hucho, eds.), Springer, Berlin, pp. 419-481 (1992)

3. P. Holzer: Experiments on the organs of dead animals. The isolated organ. In: Scientific Alternatives to Animal Experiments (F. Lembeck, ed.), Ellis Horwood, Chichester, pp. 68-72 (1989)

2. P. Holzer: Versuche an Organen getöteter Tiere. Das isolierte Organ. In: Alternativen zum Tierversuch (F. Lembeck, ed.), Georg Thieme Verlag, Stuttgart, pp. 79-84 (1988)

1. P. Holzer and F. Lembeck: Analgesia up to the 20th century. In: Discoveries in Pharmacology, vol. 1 (Psycho- and Neuropharmacology, M. J. Parnham and J. Bruinvels, eds.), Elsevier, Amsterdam, pp. 357-377 (1982)

   Back to Top
Journal Articles Books Chapters Books, Whole Conference Proceedings Other Publications Invited Lectures

5. P. Holzer (editor): Tachykinins. Handbook of Experimental Pharmacology, vol. 164. Springer, Berlin (2004)

4. H.H. Waldvogel, P. Holzer et al. (authors): Analgetika - Antinozizeptiva - Adjuvanzien. Handbuch für die Schmerzpraxis. 2., völlig überarbeitete und erweiterte Auflage. Springer, Berlin, Germany (2001)

3. M.K. Herbert, P. Holzer, and N. Roewer (editors): Problems of the Gastrointestinal Tract in Anesthesia, the Perioperative Period, and Intensive Care. Springer, Berlin, Germany (1999)

2. P. Geppetti and P. Holzer (editors): Neurogenic Inflammation. CRC Press, Boca Raton (1996)

1. Y. Taché, P. Holzer, and G.M. Rosenfeld (editors): Calcitonin Gene-Related Peptide. The First Decade of a Novel Pleiotropic Neuropeptide. Ann. New York Acad. Sci., Volume 657, New York, USA (1992)

   Back to Top
Journal Articles Books Chapters Books, Whole Conference Proceedings Other Publications Invited Lectures

28. Travis SP, Spiller RC, Holzer P, Colombel JF (2009) IBD and IBS: novel mechanisms and future practice. Preface. Dig Dis 27 Suppl 1:1-2.

27. Currò D, Holzer P (2008) New vistas on gastrointestinal motility: from physiology to therapy. An international symposium in Rome. Eur Rev Med Pharmacol Sci 12(Suppl 1):1-2.

26. Holzer P (2005) Tachykinins: relevance to irritable bowel syndrome. In: Krause G, Malagelada JR, Preuschoff U (eds) Functional Disorders of the Gastrointestinal Tract. Amsterdam: IOS Press, 103-113.

25. P. Holzer, M. Danzer, R. Schicho, and I.T. Lippe: Regulation of vagal afferent sensitivity to gastric acid. In: Gastrointestinal Inflammation and Disturbed Gut Function: The Challenge of New Concepts (G. Holtmann and N.J. Talley, eds.), Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 126-135 (2003)

24. P. Holzer, T. Michl, M. Jocič, Á. Heinemann, and R. Schuligoi: Essential role of vagal afferents in the central signalling of a gastric mucosal acid insult. In: Neurogastroenterology. From the Basics to the Clinics (H.J. Krammer and M.V. Singer, eds.), Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 697-707 (2000)

23. P. Holzer: Calcitonin gene-related peptide in gastrointestinal homeostasis. In: The CGRP Family: Calcitonin Gene-Related Peptide (CGRP), Amylin, and Adrenomedullin (D. Poyner, I. Marshall, and S.D. Brain, eds.), Landes Bioscience, Georgetown, Texas, USA, pp. 125-139 (2000)

22. P. Holzer, I.T. Lippe, M. Jocič, and Á. Heinemann: Gastric acid back-diffusion and neural alarm system. In: Problems of the Gastrointestinal Tract in Anesthesia, the Perioperative Period, and Intensive Care (M.K. Herbert, P. Holzer and N. Roewer, eds.), Springer, Berlin, pp. 329-340 (1999)

21. P. Holzer, I.T. Lippe, M. Jocič, C. Wachter, R. Amann, M.A. Pabst, Á. Heinemann, B.M. Peskar, B.A. Peskar, H.E. Raybould, E.H.Livingston, H.C. Wong, J.H. Walsh, Y. Taché, and P.H. Guth: Role of sensory neurons in the control of gastric mucosal blood flow and protection. In: Neuroendocrinology of Gastrointestinal Ulceration (S. Szabo and Y. Taché, eds.), Plenum Press, New York, pp. 1-14 (1995)

20. P. Holzer: Chemosensitive afferent nerves in the regulation of gastric blood flow and protection. In: Advances in Mucosal Immunology (J. Mestecky, M.W. Russell, S. Jackson, S.M. Michalek, H.T. Hogenova, and J. Sterzl, eds.), Plenum Press, New York, pp. 891-895 (1995)

19. P. Holzer: Peptidergic sensory neurons: neuropharmacological and pathophysiological implications. In: Sensory Neuropathies (A.K. Asbury, H. Budka, and E. Sluga, eds.), Springer, Vienna, pp. 13-24 (1995)

18. P. Holzer and I.T. Lippe: Chemoceptive afferent neurons stimulate blood flow in the acid-threatened gastric mucosa. In: Neuropeptides, Nociception, and Pain (T. Hökfelt, H.-G. Schaible, and R.F. Schmidt, eds.), Chapman & Hall, London, pp. 21-32 (1994)

17. P. Holzer: Local effector functions of primary afferent fibres. In: Cellular Mechanisms of Sensory Processing (L. Urban, ed.), Springer, Berlin, pp. 133-147 (1994)

16. P. Holzer: Spinal afferent nerves: sensory, afferent and effector functions. In: Innervation of the Gut: Pathophysiological Implications (Y. Taché, D.L. Wingate, and T.F. Burks, eds.), CRC Press, Boca Raton, pp. 123-136 (1994)

15. P. Holzer, H.E. Raybould, I.T. Lippe, R. Amann, E.H. Livingston, B.M. Peskar, B.A. Peskar, Y. Taché, and P.H. Guth: Role of sensory neuropeptides in gastric mucosal damage and protection. In: Mechanisms of Injury, Protection and Repair of the Upper Gastrointestinal Tract (A. Garner and P.E. O'Brien, eds.), John Wiley & Sons, Chichester, pp. 103-113 (1991)

14. H.E. Raybould, P. Holzer, G. Thiefin, H.H. Holzer, M. Yoneda, and Y. Taché: Vagal afferent innervation and regulation of gastric function. In: Sensory Nerves and Neuropeptides in Gastroenterology. From Basic Science to Clinical Perspectives (M. Costa, C. Surrenti, S. Gorini, C.A. Maggi, and A. Meli, eds.), Plenum Press, New York, pp. 109-127 (1991)

13. P. Holzer: Afferent nerve-mediated control of gastric mucosal blood flow and protection. In: Sensory Nerves and Neuropeptides in Gastroenterology. From Basic Science to Clinical Perspectives (M. Costa, C. Surrenti, S. Gorini, C.A. Maggi, and A. Meli, eds.), Plenum Press, New York, pp. 97-108 (1991)

12. P. Holzer: Capsaicin as a tool for studying sensory neuron functions. In: Sensory Nerves and Neuropeptides in Gastroenterology. From Basic Science to Clinical Perspectives (M. Costa, C. Surrenti, S. Gorini, C.A. Maggi, and A. Meli, eds.), Plenum Press, New York, pp. 3-16 (1991)

11. P. Holzer, U. Holzer-Petsche, and S. Leander: Tachykinins and gastrointestinal propulsion in the rat in vivo. In: Substance P and Neurokinins (J. Henry, R. Couture, A.C. Cuello, G. Pelletier, R. Quirion, and D. Regoli, eds.), Springer, New York, pp. 187-188 (1987)

10. P. Holzer, S.J. Bailey, and I.T. Lippe: Effect of tachykinins on polyphosphoinositide turnover in intestinal smooth muscle. In: Tachykinin Antagonists (R. Hakanson and F. Sundler, eds.), Elsevier, Amsterdam, pp. 231-240 (1985)

9. J. Donnerer, P. Holzer, and F. Lembeck: Release of substance P from the vascularly perfused small intestine of the guinea-pig during peristalsis. In: Substance P. Metabolism and Biological Actions (C.C. Jordan and P. Oehme, eds.), Taylor and Francis, London, p. 230 (1985)

8. P. Holzer and I.T. Lippe: Substance P hydrolyses polyphosphoinositides in intestinal smooth muscle: a link to calcium mobilization? In: Substance P. Metabolism and Biological Actions (C.C. Jordan and P. Oehme, eds.), Taylor and Francis, London, p. 229 (1985)

7. A. Bucsics, P.Holzer, I.T. Lippe, M.A. Pabst, and F. Lembeck: Density distribution of guinea-pig myenteric plexus nerve endings containing substance P and other transmitters. In: Regulation of Transmitter Function: Basic and Clinical Aspects (E.S. Vizi and K. Magyar, eds.), Akademiai Kiado, Budapest, p. 48 (1984)

6. L. Barthó, P. Holzer, F. Lembeck, J. Szolcsányi, and E.S. Vizi: Modulation of the release of substance P (SP) from enteric neurones. In: Regulation of Transmitter Function: Basic and Clinical Aspects (E.S. Vizi and K. Magyar, eds.), Akademiai Kiado, Budapest, p. 25 (1984)

5. P. Holzer: Stimulus-induced release of immunoreactive substance P from the myenteric plexus of the guinea-pig small intestine. In: Substance P - Dublin 1983 (P. Skrabanek and D. Powell, eds.), Boole Press, Dublin, pp. 243-244 (1983)

4. J. Donnerer, L. Barthó, P. Holzer, and F. Lembeck: Peristalsis and release of substance P from the vascularly perfused small intestine of the guinea-pig. In: Substance P - Dublin 1983 (P. Skrabanek and D. Powell, eds.), Boole Press, Dublin, pp. 119-120 (1983)

3. P. Holzer, U. Petsche, and I.T. Lippe: A study of the mechanisms which underlie the contractile effect of substance P on intestinal smooth muscle. In: Substance P - Dublin 1983 (P. Skrabanek and D. Powell, eds.), Boole Press, Dublin, pp. 92-93 (1983)

2. P. Holzer, L. Barthó, J. Donnerer, and F. Lembeck: Involvement of substance P in intestinal peristalsis. In: Substance P - Dublin 1983 (P. Skrabanek and D. Powell, eds.), Boole Press, Dublin, pp. 90-91 (1983)

1. F. Lembeck, R. Gamse, P. Holzer, and A. Molnar: Substance P and chemosensitive neurones. In: Neuropeptides and Neural Transmission (C.A. Marsan and W.Z. Traczyk, eds.), Raven Press, New York, pp. 51-72 (1980)

   Back to Top
Journal Articles Books Chapters Books, Whole Conference Proceedings Other Publications Invited Lectures

27. Holzer P (2011) "This paper describes a convenient, minimally invasive procedure for assessing chemically induced epigastric pain, which..." Evaluation of: [Cao Y et al. Characterization of a reproducible gastric pain model using oral capsaicin titration in healthy volunteers. Neurogastroenterol Motil. 2011 Jul; 23(7):e261-70; doi: 10.1111/j.1365-2982.2011.01734.x]. Faculty of 1000, 19 Jul 2011. F1000.com/11881962.

26. Holzer P (2011) "This paper adds an intriguing aspect to the emerging evidence that gastrointestinal microbiota have an..." Evaluation of [Bercik P et al. The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice. Gastroenterology. 2011 Apr 30; doi: 10.1053/j.gastro.2011.04.052]. Faculty of 1000, 13 Jul 2011. F1000.com/11881963

25. Holzer P (2011) "I found this article particularly interesting because it challenges the prevailing view that mustard oil..." Evaluation of [Everaerts W et al. The capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oil. Curr Biol. 2011 Feb 22; 21(4):316-21; doi: 10.1016/j.cub.2011.01.031]. Faculty of 1000, 26 Apr 2011. F1000.com/9806956

24. Holzer P (2011) "This article is a welcome guide to integrate a plethora of clinical observations and translational..." Evaluation of [Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology. 2011 Mar; 140(3):761-5; doi: 10.1053/j.gastro.2011.01.032]. Faculty of 1000, 10 Feb 2011. F1000.com/8118957

23. Holzer P (2010) "This experimental paper is remarkable by adding an intriguing aspect to the growing list of ..." Evaluation of [Gareau MG et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut. 2010 Oct 21; doi: 10.1136/gut.2009.202515]. Faculty of 1000, 16 Nov 2010. F1000.com/6142957

22. Holzer P (2004) Preface. In: Holzer P (ed) Tachykinins. Handbook of Experimental Pharmacology, Volume 164. Berlin: Springer, V-VII.

21. P. Holzer: Wie man Nobelpreisträger "produziert" - und wie das neue Gesetz genau das verhindert. Der Standard vom 10. Juli 2002

20. P. Holzer: Weniger Kleingeisterei an den Universitäten. Gastkommentar. Die Presse vom 26. April (2001)

19. P. Holzer: Informationsübertragung im Nervensystem: Neurotransmission. Katalog zur Steiermärkischen Landesausstellung in Graz (2000)

18. P. Holzer: Heilung durch Glauben oder Medizin? Denken + Glauben, Zeitschrift der Katholischen Hochschulgemeinde für die Grazer Universitäten, Nr. 105, 3-6 (2000)

17. P. Holzer: Report on the International Symposium on the Enteric Nervous System. Investigational Drugs Weekly Highlights, Week 40, p. 25-29 (1998)

16. P. Holzer: Report on the FASEB Summer Research Conference Entitled "The Cellular and Molecular Basis of Gastroduodenal Mucosal Defense". Investigational Drugs Weekly Highlights, Week 39, p. 45-49 (1998)

15. P. Holzer: Report on the First Joint Meeting of the European Neuropeptide Club (ENC, 8th Annual Meeting) and the American Summer Neuropeptide Conference (ASNC, 8th Annual Meeting). Investigational Drugs Weekly Highlights, Week 23, p. 26-29 (1998)

14. P. Holzer: Book review of "Proinflammatory and Antiinflammatory Peptides" (S.I. Said, ed.; Marcel Dekker, New York, USA 1998). Trends Pharmacol. Sci. 19, 516-517 (1998)

13. P. Geppetti and P. Holzer: Preface. In: Neurogenic Inflammation (P. Geppetti and P. Holzer, eds.), CRC Press, Boca Raton, pp. iv-v (1996)

12. P. Holzer: Power games in Austrian science. Nature 384, 404 (1996)

11. P. Holzer: Peptidergic afferent neurones in the gastrointestinal tract. The Physiological Society Magazine, No. 21., Winter (1995)

10. P. Holzer, I.T. Lippe, M. Jocič, C. Wachter, R. Erb, and Á. Heinemann: Transonic probes add direct volumetric blood flow measurement in rat studies of splanchnic circulation. Transit Times, Spring, p. 4 (1994)

9. P. Holzer, Y. Taché, and M.G. Rosenfeld: Preface. Annals of the New York Academy of Sciences 657, xiii-xiv (1992)

8. P. Holzer: Book review of "Autonomic Neuroeffector Mechanisms" (G. Burnstock and C.H.V. Hoyle, eds.; Harwood, Chur, Switzerland 1992). Trends Neurosci. 15, 355-356 (1992)

7. Y. Taché, M.G. Rosenfeld, and P. Holzer: Preface. Abstracts of the International Symposium on Calcitonin Gene-Related Peptide. 28-31 July 1991, Graz, Austria. Regul. Pept. 34, vii (1991)

6. A. Saria, C.A. Maggi, and P. Holzer: Functional and pharmacological aspects of neuropeptides: a conference report of the first meeting of the European Neuropeptide Club. Neurosci. Lett. 128, 165-168 (1991)

5. P. Holzer: Assistenten im Ausland. Österreichische Hochschulzeitung, Dezember (1988)

4. P. Holzer: Book review of "Control of nociceptive transmission in the spinal cord" (W.D. Willis; Progress in Sensory Physiology 3, D. Ottoson, ed.; Springer Verlag, Berlin 1982). Electroencephal. Clin. Neurophysiol. 56, 538-539 (1983)

3. P. Holzer and F. Lembeck: Book review of "Handbuch der experimentellen Pharmakologie. Vol. XVIII/2; Histamine II and Anti-Histaminics" (M. Roche e Silva, ed.; Springer-Verlag, Berlin 1978). Acta Med. Austriaca 8, 120 (1981)

2. F. Lembeck and P. Holzer: Book review of "Amino acids as inhibitory neurotransmitters" (S.S. Oja, P. Kontro, P. Lähdesmäki; Gustav Fischer Verlag, Stuttgart - New York 1977). Drug Res. 28, 2177 (1978)

1. P. Holzer: Charakterisierung der Atmungshemmung durch GABA an der Ratte. Ph. D. Thesis, University of Graz (1977)

   Back to Top
Journal Articles Books Chapters Books, Whole Conference Proceedings Other Publications Invited Lectures

237. P. Holzer: Brain functions depend on neural, endocrine and immune signals from the intestine. Meeting of the Austrian Society of Probiotic Medicine, Vienna, Austria, December 2011.

236. P. Holzer: Pharmacological implications of transient receptor potential channels in inflammation and pain. 10th World Congress on Inflammation, Paris, France, June 2011.

235. P. Holzer: Peripheral opioid receptor antagonists for opioid-induced constipation: prevention or withdrawal? FAME 2011, Pecs, Hungary, June 2011.

234. P. Holzer: Der Darm als neurologisches Organ. Ernährung 2011, 10. Dreiländertagung. Graz, Austria, May 2011.

233. P. Holzer: Darm und Psyche - Neurogastroenterologie. Menopause Kongress 2010. Vienna, Austria, December 2010.

232. P. Holzer: Grundlagen der Verhaltenspharmakologie. Zentrale Fortbildungsveranstaltung der österreichischen Apothekerkammer. Vienna, Austria, November 2010.

231. P. Holzer: Grundlagen der Verhaltenspharmakologie. Zentrale Fortbildungsveranstaltung der österreichischen Apothekerkammer. Salzburg, Austria, November 2010.

230. P. Holzer: Bauchschmerz und Bauchgefühle. Kongress 5 Jahre INGE St. Graz, Austria, October 2010.

229. P. Holzer: Neurobiological links between visceral dysfunction and affective disorders. 23rd Congress of the European College of Neuropsychopharmacology (ECNP). Amsterdam, The Netherlands, August 2010.

228. P. Holzer: TRP-Kanäle als molekulare Nozisensoren. 18. Wissenschaftliche Tagung der österreichischen Schmerzgesellschaft. Vienna, Austria, May 2010.

227. P. Holzer: Pharmacology of inflammatory visceral pain. Belgian Week of Gastroenterology 2010. Antwerp, Belgium, March 2010.

226. P. Holzer: Viszeraler Schmerz - Grundlagen. Schmerzakademie der österreichischen Gesellschaft für Neurologie und der österreichischen Gesellschaft für Psychiatrie und Psychotherapie. Salzburg, Austria, January 2010.

225. P. Holzer: The gut-brain axis and functional gastrointestinal disorders. Research Seminar, Biologische Heilmittel Heel GmbH, Baden-Baden, Germany, October 2009.

224. P. Holzer: Chemical sensing in the gastrointestinal tract. 59th Pharmacological Days of the Czech and Slovak Pharmacological Societies, Bratislava, Slovakia, September 2009.

223. P. Holzer: Pharmacology of inflammatory pain: local alteration in receptors and mediators. Symposium 170 on "IBD and IBS: Novel Mechanisms and Future Practice". Glasgow, UK, September 2009.

222. P. Holzer: Acid sensing of afferent neurons. Acta Physiologica International Symposium on Acid-Base Transporters and Epithelial Electrolyte Transport, Uppsala, Sweden, August 2009.

221. P. Holzer: Die Pathophysiologie der opioid-induzierten Obstipation. Herausforderungen in der Therapie der Opioid-induzierten Obstipation unter besonderer Berücksichtigung pflegerelevanter Aspekte. Eine Fortbildungsveranstaltung für Gesundheits- und Krankenpflegende. Salzburg, Austria, June 2009.

220. P. Holzer: Pharmakologische Grundlagen für die Fixkombination Oxycodon/Naloxon. 17. Wissenschaftliche Tagung der österreichischen Schmerzgesellschaft, Linz, Austria, May 2009.

219. P. Holzer: Neurogastroenterologie: Der Darm braucht starke Nerven. Antrittsvorlesung an der Medizinischen Universität Graz, Graz, Austria, April 2009.

218. P. Holzer: Neurogastroenterologie - eine Einführung. Wissenschaftliche Gesellschaft der ärzte in der Steiermark, Graz, Austria, March 2009.

217. P. Holzer: Neuropeptide Y, peptide YY and pancreatic polypeptide: gut-brain peptides. Division of Psychobiology, Department of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Germany, February 2009.

216. P. Holzer: Viszeraler Schmerz - Grundlagen. Schmerzakademie der österreichischen Gesellschaft für Neurologie und der österreichischen Gesellschaft für Psychiatrie und Psychotherapie. Salzburg, Austria, January 2009.

215. P. Holzer: Relistor und Entereg: Opiatantagonisten in der Schmerztherapie. Wissenschaftliche Gesellschaft der ärzte in der Steiermark, Graz, Austria, December 2008.

214. P. Holzer: Anxiety, stress and gut inflammation. Regional CINP Meeting, Bratislava, Slovakia, November 2008.

213. P. Holzer: Opioid receptors. International Symposium on Peptide Receptors of the Gut as Therapeutic Targets. University of Leuven, Belgium, September 2008.

212. P. Holzer: Methylnaltrexon: Eine neue Behandlungsstrategie für die opioidinduzierte Obstipation. Wyeth Expertenmeeting RelistorR, Vienna, Austria, September 2008.

211. P. Holzer: Possible implications of CGRP in IBS. Boehringer Ingelheim, Biberach an der Riss, Germany, July 2008.

210. P. Holzer: Role of opioid peptides in gastrointestinal hypomotility syndromes. International Symposium on Peptide Receptors of the Gut as Therapeutic Targets. University of Leuven, Belgium, September 2008.

209. P. Holzer: Current understanding of intestinal peristalsis and modulation of drugs. Mundipharma Research, Limburg an der Lahn, Germany, April 2008.

208. P. Holzer: Periphere Opiatrezeptorantagonisten. Wissenschaftliche Gesellschaft der ärzte in der Steiermark, Graz, Austria, March 2008.

207. P. Holzer: Der Darm braucht starke Nerven: Die Darm-Gehirn-Achse. Symposium zum Anlass des 60. Geburtstages von Frau Univ.-Prof. Mag. rer. nat. Dr. phil. Maria-Anna Pabst, Medical University of Graz, January 2008.

206. P. Holzer: New approaches to the treatment of opioid-induced bowel dysfunction. Research seminar, Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary, December 2007.

205. P. Holzer: Stress-related disorders and the gastrointestinal tract. Austrian Science Day, Bratislava, Slovakia, November 2007.

204. P. Holzer: Grundlagen der Schmerzpathologie. Jahrestagung der österreichischen Gesellschaft für Rheumatologie und Rehabilitation. Vienna, Austria, November 2007.

203. P. Holzer: Medikamentöse Therapie der Adipositas und ihre Zukunftsperspektive. Wolfsberger Präventionstage 2007, Wolfsberg, Austria, October 2007.

202. P. Holzer: New approaches to the treatment of opioid-induced constipation. International Symposium on New Vistas on Gastrointestinal Motility: from Physiology to Therapy, Rome, Italy, September 2007.

201. P. Holzer: Good Scientific Practice. Wissenschaftliche Qualitätssicherung. Institut für Zellbiologie, Histologie und Embryologie, Medical University of Graz, Austria, September 2007.

200. P. Holzer: Sensory neurons and stress: gastrointestinal mucosal defense, pain and affective behavior. Hans Selye Centennial Symposium on Stress: Basic Mechanisms and Clinical Implications, Montreal, Quebec, Canada, July 2007.

199. P. Holzer: Low-grade gastrointestinal inflammation: effects on afferent signaling and anxiety. Center for Pain Research, University of Pittsburgh Medical Center, Pittsburgh, PA, USA, May 2007.

198. P. Holzer: Neuropeptide Y type 2 and 4 receptors: roles in visceral afferent signalling and affective behaviour. Neuropeptides 2007: Functions, Dysfunctions Therapeutic Options, Santorini, Greece, April 2007.

197. P. Holzer: Reizdarm - Feueralarm ohne Brand? Fortbildungsseminar des Vollksbildungswerks Schloss St. Martin, Graz, Austria, March 2007.

196. P. Holzer: Acid sensing in the gastrointestinal tract. Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary, November 2006.

195. P. Holzer: Zukünftige pharmakologische Therapieoptionen bei Motilitätsstörungen des GI-Traktes. 8. Deutscher Interdisziplinärer Kongress für Intensivmedizin und Notfallmedizin, Hamburg, Germany, November 2006.

194. P. Holzer: Role of ASIC3 in acid hypersensitivity associated with experimental gastritis. International Symposium: From Molecules to Patients in Pain Research. Erlangen, Germany, September 2006.

193. P. Holzer: Advanced techniques for studies of gastrointestinal motility in vitro. Neurogastroenterology and Motility 2006 Joint International Meeting, Boston, MA, USA, September 2006.

192. P. Holzer: Molecular basis of visceral hyperalgesia. Annual Meeting of the European Society of Pediatric Gastroenterology and Nutrition, Dresden, Germany, June 2006.

191. P. Holzer: Involvement of the acid-sensing ion channel ASIC3 in acid hypersensitivity associated with gastritis in mice. Minisymposium of the Hungarian Pharmacological Society, Pécs, Hungary, June 2006.

190. P. Holzer: Novel targets for IBS: drugs on the horizon. Meeting of the British Society of Gastroenterology, Birmingham, UK, March 2006

189. P. Holzer: Neuropharmacology of the gut-brain axis. Institute of Pharmacology, School of Medicine, Catholic University of the Sacred Heart, Rome, Italy, February 2006

188. P. Holzer: Viszerale Schmerzforschung: scharf und sauer. Netzwerktreffen der Initiative Gehirnforschung in der Steiermark, Graz, Austria, January 2006

187. P. Holzer: Enteric - sensory neuron interactions AstraZeneca, Mölndal, Sweden, January 2006

186. P. Holzer: Blood flow in the irritable and inflamed bowel. AstraZeneca, Mölndal, Sweden, January 2006

185. P. Holzer: Neue Prokinetika für den gehemmten Darm. 29. Seminar der österreichischen Gesellschaft für Chirurgische Forschung, Gosau, Austria, November 2005

184. P. Holzer: Neuropharmakologie der Darm-Gehirn-Achse. Medizinische Universität Graz, Graz, Austria, June 2005

183. P. Holzer: TRPV1 and ASIC ion channels in gastric pain. Ninth Meeting of the Austrian Neuroscience Association, Obergurgl, Austria, June 2005

182 P. Holzer: Zukünftige pharmakologische Therapieoptionen bei Motilitätsstörungen des GI-Traktes. 7. Deutscher Interdisziplinärer Kongress für Intensivmedizin und Notfallmedizin, Hamburg, Germany, December 2004

181. P. Holzer: Roles of TRPV1 in gastrointestinal function. Kitasato University School of Medicine, Sagamihara, Japan, November 2004

180. P. Holzer: Sensory neurons and nociception in the gastrointestinal tract. Symposium of the IUPHAR GI Section on "Advances in GI Pharmacology", Otsu, Japan, November 2004

179. P. Holzer: The gut-brain axis: coordination of local and systemic reactions to gastrointestinal noxae. Satellite Symposium of the 32nd Annual Meeting of the Japanese Society of Ulcer Research, Otsu, Japan, November 2004

178. P. Holzer: The vanilloid (TRPV) receptor family: what's hot about capsaicin? XIIth European Symposium on Neurogastroenterology and Motility, Cambridge, UK, September 2004

177. P. Holzer: Efferent-like roles of afferent neurons in the gut: blood flow regulation and tissue protection. Pavlov Centenary Symposium: "Integrative Physiology & Behaviour", St. Petersburg, Russia, June 2004

176. P. Holzer: Dyspepsie. 12th Scientific Meeting of the Austrian Pain Society, Graz, Austria, May 2004

175. P. Holzer: Potential effects on sensory neuropeptides. Expert Panel Workshop on "Clinical Safety of DPP-4 Inhibitors", Novartis, Basel, Switzerland, May 2004

174. P. Holzer: Focus on sensory neurons. Workshop on "Therapeutic Approaches for Treating IBS", Altana Pharma, Konstanz, Germany, April 2004

173. P. Holzer: Afferent signalling of gastric acid challenge. Second International Symposium on Brain-Gut Axis: Basic and Clinical Aspects, Cracow, Poland, November 2003

172. P. Holzer: Pharmakologische Untersuchungen zur Darmperistaltik (Tachykinine, Opiate, Prostanoide) und Colon-Durchblutung (5-HT-Rezeptorliganden). Solvay Pharmaceuticals, Hannover, Germany, October 2003

171. P. Holzer: Neuropharmacology of the gut-brain axis. Kolloquium des Graduiertenkollegs "Biologische Grundlagen von Erkrankungen des Nervensystems", Otto-von-Guericke-Universität, Magdeburg, Germany, October 2003

170. P. Holzer: Protection from acid in the upper gut: a model system for visceral nociception. Neurology and GI Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development, Harlow, Essex, UK, September 2003

169. P. Holzer: Pharmacotherapy of gastrointestinal functions. First European Summer School of Neurogastroenterology, Haigerloch, Germany, August 2003

168. P. Holzer: Tachykinins as drug targets in the enteric nervous system. International Symposium on the Enteric Nervous System, Banff, Alberta, Canada, July 2003

167. P. Holzer: Interaktionen zwischen Immun- und Nervensystem im Verdauungstrakt: Konsequenzen für Nozizeption, Protektion und Entzündung. Forschungskolloquium des SFB Regulation von Immunfunktion im Verdauungstrakt, Faculty of Medicine, University of Regensburg, Germany, June 2003

166. P. Holzer: Tachykininergic regulation of colonic motor function. International Workshop on Colonic Motility, Providence, Rhode Island, USA, June 2003

165. P. Holzer: Capsaicin and the gastrointestinal tract. Centennial Scientific Session on the Occasion of the Anniversary of the Birthday of Miklós Jancsó, University of Szeged, Hungary, April 2003

164. P. Holzer: Modification of guinea-pig intestinal peristalsis in vitro by opiate and prostanoid receptor ligands. XVth Belgian Week of Gastroenterology, Brugge, Belgium, February 2003

163. P. Holzer: Das enterale Nervensystem als Schaltzentrale im Darmtrakt. Department of Histology and Embryology, University of Graz, Austria, February 2003

162. P. Holzer: Der Darm als neurologisches Organ: eine Herausforderung für die Neuropharmakologie. Department of Pharmacology and Toxicology, University of Freiburg, Germany, November 2002

161. P. Holzer, M. Danzer, R. Schicho, and I.T. Lippe: Afferent signalling of gastric acid challenge: inhibition by antisecretory drugs and exacerbation by cytokines. Falk Symposium on GI Inflammation and Disturbed Gut Function: The Challenge of New Concepts, Freiburg, Germany, October 2002

160. P. Holzer: Afferents and mucosal protection. Eleventh European Symposium on Neurogastroenterology and Motility, Tübingen, Germany, October 2002

159. P. Holzer: Tachykinins: relevance to gut function in health and disease. International Solvay Symposium on Gut Feelings and Movements, Sitges (Barcelona), Spain, September 2002

158. P. Holzer: Neurogenic inflammation and protection. Twelfth Biennial American Motility Society Meeting, Galveston, Texas, USA, September 2002

157. P. Holzer: Gastrointestinal afferents as targets for novel drugs. Second Annual Meeting of the Neurogastroenterology and Motility Section of the British Society of Gastroenterology, London, United Kingdom, September 2002

156. P. Holzer: Ein goldenes Zeitalter der Pharmakologie. Wissenschaftliches Fest anläßlich des 80. Geburtstags von Fred Lembeck, Graz, Austria, July 2002

155. P. Holzer: Neural responses to gastric mucosal acid challenge. Department of Pharmacology, University of Iowa, Iowa City, Iowa, United States of America, May 2002

154. P. Holzer: Research into dyspeptic pain. Giulio Bertaccini Memorial Lecture 2002. University of Parma, Parma, Italy, May 2002

153. P. Holzer, M. Danzer, R. Schicho, and I.T. Lippe: Neue Ansätze zu Verständnis und Therapie der funktionellen Dyspepsie. Symposium of the Wissenschaftliche Gesellschaft der Ärzte in der Steiermark, Graz, Austria, March 2002

152. P. Holzer: Parallele Untersuchung der Peristaltik an multiplen isolierten Darmsegmenten eines Versuchstieres. Bundesministerium für Bildung, Wissenschaft und Kultur, Vienna, Austria, December 2001

151. P. Holzer: Der Darm als neurologisches Organ. Lecture of the Year. Department of Paediatric Surgery, University of Graz, Austria, December 2001

150. P. Holzer: Laudatio zur Verleihung der Ehrenmitgliedschaft der Österreichischen Gesellschaft für Pharmakologie an Fred Lembeck, Wien, Austria, November 2001

149. P. Holzer: Neurogenic peptides: potential influence of DPP-IV inhibitors on neurogenic inflammation. Workshop on Safety of DPP-IV Inhibitors, Novartis AG, Basel, Switzerland, November 2001

148. P. Holzer: Experimental neurogastroenterology: research towards functional bowel disorders. Department of Gastrointestinal Research, Pfizer, Nagoya, Japan, October 2001

147. P. Holzer: Capsaicin-sensitive afferent neurons in the gastrointestinal tract: neural emergency system. Digestive Disease Week Japan, Kyoto, Japan, October 2001

146. P. Holzer: Capsaicin-sensitive afferent neurons in the gastrointestinal tract. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Graduate School of Medicine, University of Kyoto, Japan, October 2001

145. P. Holzer, R. Schicho, M. Danzer, M. Jocič, T. Michl, and I.T. Lippe: Central and peripheral neural responses to chemical insults of the gastric mucosa. Conference on Gastrointestinal Response to Injury: Canada 2001, Chateau Montebello, Quebec, Canada, October 2001

144. P. Holzer: Sensory nerves as targets for drugs to treat functional bowel disorders. Third Croatian Congress of Pharmacology, Zagreb, Croatia, September 2001

143. P. Holzer: Surveillance of the gastrointestinal mucosa by sensory neurons. International Symposium Brain-Gut Axis in Gastrointestinal Protection and Damage, Cracow, Poland, September 2001

142. P. Holzer: Enteric neurophysiology. Back to the roots: gut feelings about a little brain. Seventh Meeting of the Austrian Neuroscience Association, Seggau, Austria, September 2001

141. P. Holzer: Neuropharmacological opportunities to interfere with the sensory system of the gut. Third Meeting of the Federation of the European Pharmacological Societies (EPHAR), Lyon, France, July 2001

140. P. Holzer: Neurale Reaktionen auf Schädigung der gastrointestinalen Mukosa. Annual Meeting of the Arbeitskreis Neurogastroenterologie und Motilität, Tutzing, Germany, March 2001

139. P. Holzer: Enteric reflexes. Novartis Workshop on Perspectives on Future Therapy of Functional GI Diseases, London, United Kingdom, February 2001

138. P. Holzer: Neurotransmitter: neue Aspekte bei Depression und Sucht. Fortbildungsseminar an der Landesnervenklinik Sigmund Freud, Graz, Austria, December 2000

137. P. Holzer: Capsaicin in visceral nociception and homeostasis. Third Congress of European Federation of IASP Chapters, Nice, France, September 2000

136. P. Holzer: Ulkus und Nerven - erklärt der Helicobacter pylori alles? Forschungsforum Neurogastroenterologie, 55. Tagung der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten, Hamburg, Germany, September 2000

135. P. Holzer: Ulkus und Nerven - erklärt der Helicobacter pylori alles? Kliniknachmittag, Department of Medicine, University of Graz, Austria, July 2000

134. P. Holzer: Tachykinins and other targets of afferent neurons: a key to understand gut hyperalgesia? International Symposium on Brain-Gut Axis: from Basic to Clinical Science, Toulouse, France, July 2000

133. P. Holzer: Inflammation and gut hypersensitivity: peripheral mechanisms. Tenth European Symposium on Neurogastroenterology and Motility, Bologna, Italy, June 2000

132. P. Holzer: Experimentelle Neurogastroenterologie. Symposium of the Wissenschaftliche Gesellschaft der Ärzte in der Steiermark, Graz, Austria, June 2000

131. P. Holzer: Neuropharmacology of dyspepsia. AstraZeneca Lecture, CURE Digestive Dieseases Research Center, University of California, Los Angeles, United States of America, May 2000

130. P. Holzer: Neuropeptides in the gastrointestinal tract. Tenth Annual Meeting of the European Neuropeptide Club, Innsbruck, Austria, May 2000

129. P. Holzer: Vagal afferent signalling of a gastric acid insult: an experimental model of dyspepsia. Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Slovakia, April 2000

128. P. Holzer: Neuroimmunology of gastric mucosal disease: immune system - sensory neuron interaction as a clue for dyspepsia? Session of the Projektteam Hirnforschung at the Bundesministerium für Wissenschaft und Verkehr, Vienna, Austria, April 2000

127. P. Holzer: Pharmakologie von Capsaicin and Vanilloid-Rezeptoren. Workshop der Generaldirektion für öffentliche Sicherheit, Vienna, Austria, February 2000

126. P. Holzer: Afferent signalling and central processing (expression of c-fos mRNA) of noxious acid stimuli in the stomach. Boehringer Ingelheim Pharma KG, Ingelheim, Germany, January 2000

125. P. Holzer: Communication between immune cells, nerves, smooth muscle cells and enterocytes. European Postgraduate Gastro-Surgical School: Motility Disorders of the Lower Gastrointestinal Tract: from Basic Science to Therapy, Amsterdam, The Netherlands, December 1999

124. P. Holzer: Tachykinins in the gut. International Symposium on Substance P in honour of Bengt Pernow on the occasion of his 75th birthday, Stockholm, Sweden, November 1999

123. P. Holzer: Role of afferent neurons in gastric mucosal pathophysiology. Second European Congress of Pharmacology, Budapest, Hungary, July 1999

122. P. Holzer, T. Michl, M. Jocič, Á. Heinemann, and R. Schuligoi: Vagal afferent signalling of acid insult in rat gastric mucosa. Falk Symposium on Neurogastroenterology - From the Basics to the Clinics, Freiburg, Germany, June 1999

121. P. Holzer: Neuropeptides and other pharmacological targets on sensory neurons. Giulio Bertaccini Symposium on Histaminergics, Peptides and Gastrointestinal Drugs, Parma, Italy, May 1999

120. P. Holzer: Local microcirculatory reflexes and afferent signalling in response to gastric acid challenge. International Workshop on The Enteric Nervous System - A Basic Approach to the Understanding of GI Diseases, Delray Beach, Florida, United States of America, March 1999

119. P. Holzer: Vergleichende Pharmakologie: Capsaicin und synthetisches Capsaicin. Workshop der Generaldirektion für öffentliche Sicherheit, Vienna, Austria, February 1999

118. P. Holzer: Pharmakologie der Makrolide. Workshop über die Therapie von Atemwegsinfektionen, Graz, Austria, February 1999

117. P. Holzer: Pharmakologie chemosensitiver afferenter Neurone des Magens. Faculty of Science, University of Innsbruck, Austria, December 1998

116. P. Holzer: Neuropharmakologie. Interdisziplinäres Seminar über das Verhältnis von Geist und Gehirn, Faculty of Theology, University of Graz, Austria, December 1998

115. P. Holzer: Pharmakologie afferenter Neurone. Fachbereich Humanmedizin, Philipps-Universität Marburg, Germany, December 1998

114. P. Holzer: Pharmacology of afferent neurons: capsaicin, peptides and beyond. 4th Scientific Meeting of the Austrian Pharmacological Society, Vienna, Austria, November 1998

113. P. Holzer: Gastric acid-evoked c-fos messenger RNA expression in rat brainstem is inhibited by desipramine and facilitated by yohimbine. 30th Conference of the European Gastro Club, Münster, Germany, October 1998

112. P. Holzer: Gastric acid backdiffusion and neural emergency system. International Symposium on Problems of the Gastrointestinal Tract in Anaesthesia, the Perioperative Period, and Intensive Care, Würzburg, Germany, October 1998

111. P. Holzer, R. Schuligoi, and M. Jocič: Expression of c-fos in the brainstem after gastric acid challenge. 11th World Congress of Gastroenterology, Wien, Austria, September 1998

110. P. Holzer: Enteric nervous system control of gastrointestinal blood flow. International Symposium on the Enteric Nervous System, Centre for Gastroenterological Research at the University of Göteborg, Göteborg, Sweden, September 1998

109. P. Holzer: Brainstem responses to mucosal injury determined by c-fos mRNA expression. FASEB Summer Research Conference on The Cellular and Molecular Basis of Gastroduodenal Mucosal Defense, Wilsonville, Oregon, United States of America, August 1998

108. P. Holzer: Neural emergency system in the stomach. XIIIth International Congress of Pharmacology, Munich, Germany, July 1998

107. P. Holzer: CGRP in gastrointestinal homeostasis. Third International Symposium on Calcitonin Gene-Related Peptide, Shaftesbury, Dorset, United Kingdom, May 1998

106. P. Holzer: Viszeraler Schmerz. Seventh Meeting of the Austrian Society for the Study of Pain, Graz, Austria, April 1998

105. P. Holzer: Afferent neurons in gastric mucosal homeostasis and pain. Pfizer Central Research, Aichi, Japan, December 1997

104. P. Holzer: Afferent signalling of gastric acid injury to the rat brainstem. Symposium on Brain-Gut Interactions, University of Nagoya, Japan, December 1997

103. P. Holzer: Neural regulation of gastric mucosal homeostasis. Alimentary Disease Week, Hong Kong, P.R. China, December 1997

102. P. Holzer: Tachykininantagonisten und deren klinische Einsatzmöglichkeit. Collegium für Therapieforschung "Vom Rezeptor zur Therapie in der Gastroenterologie", Munich, Germany, December 1997

101. P. Holzer: Tachykinins in inflammation and motility. International Workshop on "Immunomodulation of Gastrointestinal Motility", Leuven, Belgium, December 1997

100. P. Holzer: Tachykinine im Gastrointestinaltrakt. Department of Pharmacology, University of Kiel, Germany, November 1997

99. P. Holzer: Control of intestinal peristalsis by tachykinins acting via NK1 and NK2 and NK3, receptors. International Meeting on Tachykinins in Health and Disease, Cairns, Queensland, Australia, September 1997

98. P. Holzer: Role of sensory nerves in gastroprotection. XXXIII International Congress of Physiological Sciences, St. Petersburg, Russia, July 1997

97. P. Holzer: Gastroprotektion, Gastroparese und Schmerz: die vielen Seiten eines neuralen Notfallsystems im Magen. Department of Anaesthesiology, University of Würzburg, Germany, June 1997

96. P. Holzer: Neuropeptides in inflammatory diseases of the gut - state of the art. Seventh Annual Meeting of the European Neuropeptide Club, Marburg, Germany, May 1997

95. P. Holzer: Sensory neurons and neuropeptides in the control of gastric cell damage and repair. Gastrointestinal Forum on Molecular Biological Approach to Gastrointestinal Disease, Washington, D.C., United States of America, May 1997

94. P. Holzer: Peptidergic afferents as gastrointestinal emergency system. Second Joint Meeting of the European Neuropeptide Club and the Winter Neuropeptide Conference, Kitzbühel, Austria, February 1997

93. P. Holzer: Multiple homeostatic roles of nociceptive nerves in the stomach. Fourth Conference of the Hungarian Neuroscience Association, Gödöllö, Hungary, January 1997

92. P. Holzer: Capsaicin-sensitive visceral afferents: inflammatory mediators and genesis of hyperalgesia. 5th United European Gastroenterology Week, Paris, France, November 1996

91. P. Holzer: The homeostatic role of sensory neurons in the gastric mucosa. I.N.S.E.R.M. Unité de Recherches de Physiopharmacologie du Système Nerveux, Paris, France, November 1996

90. P. Holzer: Functional role of peptidergic sensory neurones in the control of microvascular blood flow. 6th World Congress for Microcirculation, Munich, Germany, August 1996

89. P. Holzer: Neural Mechanisms in Gastroprotection and Secretory Function. Digestive Disease Week, San Francisco, California, United States of America, May 1996

88. P. Holzer, M.K. Herbert, M. Jocič, and B.A. Peskar: Laser-Doppler Flowmetrie in der Rattenhaut - Bedeutung von Stickstoffmonoxyd (NO) bei neurogener Vasodilatation.

87. P. Holzer: Tachykinin antagonists and gut function: preclinical pharmacology. International Course on Tachykinins in Gastroenterology and Pneumology: from Pharmacology to Clinical Perspectives, Florence, Italy, October 1995

86. P. Holzer: Nitric oxide: a pleiotropic messenger molecule. First Meeting of the Slovenian Biochemical Society, Portoroz, Slovenia, September/October 1995

85. P. Holzer: Nitric oxide: a new messenger in inflammation. Meeting "Life Sciences 1995", Gozd Martuljek, Slovenia, September 1995

84. P. Holzer: NO:PG:CGRP pathway in neurogenic vasodilatation; CGRP and gastrointestinal tract. CGRP Expert Meeting, Department of Cardiovascular Pharmacology, Dr. Karl Thomae GmbH, Biberach, Germany, August 1995

83. P. Holzer: Sensory afferent nerves and mucosal defense. FASEB Summer Research Conference: The Cellular and Molecular Basis of Gastroduodenal Mucosal Defense, Saxtons River, Vermont, United States of America, August 1995

82. P. Holzer: The role of peptidergic afferent neurons in the gastrointestinal tract. Summer Meeting of the Physiological Society, Oxford, United Kingdom, July 1995

81. P. Holzer: Actions of sensory neuropeptides in the gastrointestinal tract. Fifth Annual Meeting of the European Neuropeptide Club, Lund, Sweden, June 1995

80. P. Holzer: Spices, nerves and peptides. CURE Gastroenteric Biology Center, School of Medicine, University of California at Los Angeles, United States of America, May 1995

79. P. Holzer: Neurogenic vasodilatation in the skin: interactions between interleukin-1, NO, prostaglandins and CGRP. Anaesthesiology Research Laboratory, School of Medicine, University of California at San Diego, United States of America, May 1995

78. P. Holzer: Neuropeptides in gastrointestinal disease. Second ENC Winter Discussion: Neuropeptides and Transmitters in Disease, Seefeld, Austria, January 1995

77. P. Holzer: Pharmacology of capsaicin and neuropeptides. Department of Pharmacology, Kyoto Pharmaceutical University, Kyoto, Japan, November 1994

76. P. Holzer: CGRP, NO, bradykinin and other mediators of blood flow responses to gastric acid injury. 8th International Conference on Ulcer Research, Kyoto, Japan, November 1994

75. P. Holzer: Involvement of sensory neurons in gastric functions. Department of Pharmacology, University Medical School of Pécs, Hungary, October 1994

74. P. Holzer: Sensory nerve endings, nitric oxide and NANC vasodilatation. Third Workshop on Non-Adrenergic Non-Cholinergic Mechanisms, Gent, Belgium, September 1994

73. P. Holzer, C. Wachter, Á. Heinemann, M. Jocič, and I.T. Lippe: Diverse interactions of CGRP and NO in the gastric and cutaneous microcirculation. The Second International Symposium on CGRP, Montreal, Canada, August 1994

72. P. Holzer: The role of sensory nerves and CGRP in vascular homeostasis following acid injury to the gastric mucosa. 14th Annual Meeting of the Bayliss and Starling Society, Southampton, United Kingdom, July 1994

71. P. Holzer: Sensorische Neuropeptide in Magen und Haut: Relevanz für Gewebeprotektion und Entzündung. Department of Pharmacology, University of Vienna, Austria, June 1994

70. P. Holzer: Mediators of vascular response to acid backdiffusion: implication in resistance to injury. Digestive Disease Week, New Orleans, Louisiana, United States of America, May 1994

69. P. Holzer: Tachykinins and intestinal motility Fourth Annual Meeting of the European Neuropeptide Club, Strasbourg, France, April 1994

68. P. Holzer: Blood flow control by peptidergic afferent neurons. Basic Neuroscience and Neurochemistry, Austrian-Hungarian Joint Meeting, Sopron, Hungary, September 1993

67. P. Holzer: Role of afferent nerves in the control of gastric blood flow. Department of Medicine, University of Southern California, Los Angeles, United States of America, June 1993

66. P. Holzer: Acid-induced gastric hyperemia: an update CURE, Department of Medicine, University of California at Los Angeles, United States of America, June 1993

65. P. Holzer: Peptiderge afferente Neurone in der Steuerung vaskulärer Funktionen. Neurobiologisches Kolloquium, Department of Zoology, University of Graz, Austria, May 1993

64. P. Holzer: Protektive Funktion von Neuropeptiden im Gastrointestinaltrakt. Faculty of Medicine, University of Freiburg, Germany, April 1993

63. P. Holzer: Regulatory roles of sensory nerves in the gut. XXI International Congress of Neurovegetative Research, Bologna, Italy, April 1993

62. P. Holzer: Sensory neurons in the gastrointestinal tract. NATO Advanced Research Workshop on the Cellular Mechanisms of Sensory Processing, Ashford, Kent, United Kingdom, April 1993

61. P. Holzer: Role of sensory nerves in the regulation of gastric blood flow and protection. 77th Conference of the Kyoto Gastrointestinal Research Forum, Kyoto, Japan, November 1992

60. P. Holzer: Säuresensitive peptiderge Neurone als Schutzfaktoren der Magenmukosa. Fakultät für Theoretische Medizin, University of Ulm, Germany, October 1992

59. P. Holzer: Chemoceptive afferent neurons stimulate blood flow in the acid-threatened gastric mucosa. International Symposium on Neuropeptides, Nociception and Pain, Mainz, Germany, October 1992

58. P. Holzer: Chemosensitive afferent nerves in the regulation of gastric mucosal blood flow and protection. 7th International Congress of Mucosal Immunology, Prague, Czechoslovakia, August 1992

57. P. Holzer: Role of sensory nerves in gastrointestinal blood flow regulation and mucosal injury. Third FASEB Summer Research Conference: Physiology and Pathophysiology of the Splanchnic Circulation, Copper Mountain, Colorado, United States of America, July 1992

56. P. Holzer: Spinal afferent nerves: sensory, afferent and effector functions. Second International Symposium on Brain-Gut Interactions, Cambridge, United Kingdom, July 1992

55. P. Holzer: Evidence for an essential protective role of neuropeptides in the gastrointestinal tract. 14th European Workshop on Inflammation Joint Meeting with the British Inflammation Research Association, London, United Kingdom, July 1992

54. P. Holzer: Bedeutung afferenter Neurone für die Mikrozirkulation der Magenmukosa. Department of Biochemistry, Dr. Karl Thomae GmbH, Biberach, Germany, May 1992

53. P. Holzer: Neurale Regulation der Magendurchblutung bei Säurebelastung der Mukosa. Fakultät für Theoretische Medizin, University of Heidelberg, Germany, April 1992

52. P. Holzer: Neurale Regulation der Magendurchblutung bei Säurebelastung der Mukosa. Faculty of Medicine, University of Graz, Austria, March 1992

51. P. Holzer: Regelung der Magenschleimhautdurchblutung im Zusammenhang mit der Säurerückdiffusion: Axonreflex oder autonomer Reflex? Max-Planck-Institut für Physiologische und Klinische Forschung, Bad Nauheim, Germany, March 1992

50. P. Holzer: The neurohormonal control of gastric secretion and circulation. Postgraduate Medical School in Gastroenterology, Department of Internal Medicine, University of Padova, Padova, Italy, February 1992

49. P. Holzer: Neurohormonal control of gastric secretion and circulation. Postgraduate Medical School in Gastroenterology, Gastroenterology Unit of the Department of Pathophysiology, University of Florence, Florence, Italy, February 1992

48. P. Holzer: Die Rolle afferenter Neurone in der Regulation der Magenschleimhaut-Durchblutung. Department of Physiology and Biokybernetics, University of Erlangen, Germany, February 1992

47. P. Holzer: Neurogenic inflammation: an introduction. International Round Table on Neurogenic Inflammation, Sandoz Forschungsinstitut, Vienna, Austria, January 1992

46. P. Holzer: Sensorische Nerven in der Magenschleimhaut: Bedeutung für Durchblutung und Protektion. Gastroenterologisches Kolloquium, Medizinische Klinik, Philipps-Universität Marburg, Germany, December 1991

45. P. Holzer: Sensorische Nerven in der Kontrolle der Magen-Mikrozirkulation. Zentrum der Inneren Medizin, Johann Wolfgang Goethe Universität Frankfurt, Germany, December 1991

44. P. Holzer: Peptidergic nociceptive afferents in the control of the vascular and immune responses to injury. International Congress of the Dutch Association of Physiotherapy in Sports Health Care on Overuse Injuries, Maastricht, The Netherlands, September 1991

43. P. Holzer: Role of CGRP in gastrointestinal blood flow. International Symposium on Calcitonin Gene-Related Peptide, Graz, Austria, July 1991

42. P. Holzer: Neuropeptide und ihre Funktion. Department of Histology and Embryology, University of Graz, Austria, June 1991

41. P. Holzer: Role of sensory neurons in cutaneous pathophysiology. Joint Meeting of the Society of Cutaneous Ultrastructure Research and the Japanese Society for Cutaneous Ultrastructural Biology, Vienna, Austria, May 1991

40. P. Holzer: Role of sensory neuropeptides in gastric mucosal blood flow and protection. First International Meeting of the European Neuropeptide Club: Functional and Pharmacological Aspects of Neuropeptides, Igls near Innsbruck, Austria, January 1991

39. P. Holzer: Occurrence, distribution and functional significance of capsaicin-sensitive neurons. 25th National Congress of the Italian Society of Pharmacology, Symposium on Sensory Neuropeptides: Pathophysiological Roles and Therapeutic Prospects, Taormina - Giardini Naxos, Italy, October 1990

38. P. Holzer: Peptidergic sensory neurons: neuropharmacologic and pathophysiologic implications. International Congress on Neuromuscular Diseases Satellite Symposium on Sensory Neuropathies, Vienna, Austria, September 1990

37. P. Holzer: Role of sensory neuropeptides in gastric mucosal damage and protection. Satellite Meeting of the World Congress of Gastroenterology on Mechanisms of Injury, Protection and Repair of the Upper Gastrointestinal Tract, Cairns, Australia, August 1990

36. P. Holzer: Role of peptidergic sensory neurons in gastric mucosal blood flow and protection. Center for Neuroscience, Flinders University of South Australia, Adelaide, Australia, August 1990

35. P. Holzer: Recent advances in research on capsaicin. Center for Neuroscience, Flinders University of South Australia, Adelaide, Australia, August 1990

34. P. Holzer: Role of substance P in gastric mucosal blood flow and protection. Pfizer Central Research Division, Groton, CT, USA, July 1990

33. P. Holzer: Role of peptidergic sensory neurons in gastric mucosal blood flow and protection. International Meeting on Substance P and Related Peptides: Cellular and Molecular Physiology, Worcester, Massachusetts, USA, July 1990

32. P. Holzer: Gastric mucosal protection mediated by sensory neurons. International Symposium on Defense Mechanisms in the Digestive System, Prague, Czechoslovakia, July 1990

31. P. Holzer: A novel protective mechanism: sensory nerve-mediated gastric mucosal vasodilatation. XIth International Congress of Pharmacology, Amsterdam, The Netherlands, July 1990

30. P. Holzer: Sensory nerves and gastric mucosal blood flow. Mini-Symposium on Recent Advances in Research of Sensory Peptides and Capsaicin Mechanisms, Bad Nauheim, Germany, June 1990

29. P. Holzer: Sensorische Nerven in der Magenschleimhaut: Rolle bei Durchblutung und Protektion. II. Medizinische Klinik und Poliklinik, Technical University of Munich, Germany, June 1990

28. P. Holzer: Mechanismen der Magensäuresekretion und Cytoprotektion. Annual Meeting of the Wissenschaftliche Gesellschaft der Ärzte in der Steiermark, Bad Aussee, Austria, June 1990

27. P. Holzer: Afferent neurons and gastric mucosal protection. Gastrointestinal Research Group, Department of Medical Physiology, University of Calgary, Calgary, Alberta, Canada, May 1990

26. P. Holzer, I.T. Lippe, M.A. Pabst, B.M. Peskar, B.A. Peskar, E.H. Livingston, and P.H. Guth: Afferent nerve-mediated control of gastric mucosal blood flow and protection. First International Meeting on Sensory Nerves and Neuropeptides in Gastroenterology: from Basic Science to Clinical Perspectives, Florence, Italy, December 1989

25. P. Holzer: Capsaicin as a tool for studying sensory nerves. First International Meeting on Sensory Nerves and Neuropeptides in Gastroenterology: from Basic Science to Clinical Perspectives, Florence, Italy, December 1989

24. P. Holzer: The role of sensory neurons in gastric mucosal blood flow and protection. Gastrointestinal Research Laboratory, Department of Surgery, University of California San Francisco, San Francisco, California, United States of America, October 1989

23. P. Holzer: Sensory nerves in gastric mucosal protection. Division of Physiology and Pharmacology, Department of Biomedical Sciences, McMaster University Medical School, Hamilton, Ontario, Canada, September 1989

22. P. Holzer: Sensory nerves in the control of gastric mucosal blood flow and protection. Hans Selye Symposium on Neuroendocrinology and Stress: Neuroendocrinology of Gastrointestinal Ulceration, Estérel, Quebec, Canada, September 1989

21. P. Holzer: Tachykinins and enteric motor activity. XIIth International Symposium on Gastrointestinal Motility, Gmunden, Austria, September 1989

20. P. Holzer: Sensory nerves signal an increase in gastric mucosal blood flow in response to acid back-diffusion and injury. Second International Symposium on Cell Injury and Cytoprotection, Harvard Medical School, Boston, Massachusetts, United States of America, July 1989

19. P. Holzer: Afferent nerve mediation of gastric mucosal protection. CURE All Day Research Meeting, Los Angeles, California, United States of America, March 1989

18. P. Holzer: Die Pharmakologie des Peristaltikreflexes im Dünndarm des Meerschweinchens. Department of Biochemistry, Dr. Karl Thomae GmbH, Biberach, Germany, November 1988

17. P. Holzer, I.T. Lippe, M.A. Pabst, and M. Lorbach: Afferent nerve endings may protect gastric mucosa by a local release of neuropeptide transmitters. 6th International Conference on Experimental Ulcer, Jerusalem, Israel, August 1988

16. P. Holzer: Capsaicin-empfindliche afferente Neurone schützen gegen Ulcusentstehung in der Magenschleimhaut: Beteiligung von Neuropeptiden. Max-Planck-Institut für Physiologische und Klinische Forschung, Bad Nauheim, Germany, June 1988

15. P. Holzer and I.T. Lippe: Afferent neurones involved in gastric mucosal protection: possible mechanisms. Symposium on Nerve Fibres and Inflammation, Erlangen, Germany, March 1988

14. P. Holzer, I.T. Lippe, and W. Sametz: Aktivierung afferenter Neurone schützt vor Magenulceration. Symposium of the Wissenschaftliche Gesellschaft der Ärzte in der Steiermark, Graz, Austria, December 1987

13. P. Holzer: Capsaicin-sensitive afferent neurones and their possible role in the pathogenesis of peptic ulcer disease. Department of Clinical Pathophysiology, University of Florence, and Department of Pharmacology, Menarini Pharmaceuticals, Florence, Italy, October 1987

12. P. Holzer: Bedeutung von sensorischen Neuronen bei Darmatonie und Ulcus. Interdisciplinary Workshop, Faculty of Medicine, University of Vienna, Austria, March 1987

11. P. Holzer: Inositol phosphates and diacylglycerol as second messengers. Department of Pharmacology, University Medical School, Pécs, Hungary, November 1986

10. P. Holzer: Neurokinins in sensory fibres, with implications for disease. Symposium on the Autonomic Nervous System in Health and Disease, Leeds Castle, United Kingdom, October 1986

9. P. Holzer: Role of peptidergic nerves in gastrointestinal function. Slovak Academy of Sciences, Bratislava, Czechoslovakia, December 1985

8. P. Holzer: Involvement of capsaicin-sensitive sensory neurones in gastrointestinal function. 50th Jubilee Congress of the Hungarian Physiological Society, Symposium on Capsaicin and the Sensory System, Budapest, Hungary, July 1985

7. P. Holzer, S.J. Bailey, and I.T. Lippe: Effect of tachykinins on polyphosphoinositide turnover in intestinal smooth muscle. Fernström Symposium on Tachykinin Antagonists, Lund, Sweden, June 1985

6. P. Holzer: Freisetzung und Wirkung von Substanz P am Darm. Neuroscience Workshop, Department of Pharmacology, University of Vienna, Austria, April 1984

5. P. Holzer: Experimentelle und klinische Pharmakologie der Darmperistaltik. Symposium of the Wissenschaftliche Gesellschaft der Ärzte in der Steiermark, Graz, Austria, November 1983

4. P. Holzer: Pharmakologische Beeinflussung von Dünndarmfunktionen. Colloquium publicum, Department of Paediatrics, University of Graz, Austria, March 1983

3. P. Holzer: Substanz P und Darmperistaltik. Symposium of the Ernst Boehringer-Foundation, Vienna, Austria, November 1982

2. P. Holzer: Distribution of capsaicin-sensitive fibers: functional implications. Second European Winter Conference on Brain Research, Chamonix, France, March 1982

1. P. Holzer: Substanz P-Rezeptoren im glatten Muskel: Welche Ionenkanäle? Symposium of the Ernst Boehringer-Foundation, Vienna, Austria, November 1981

   Back to Top


28.08.2011